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Abstract 
 Mastitis is an economically distressing disease in the dairy industry.  Bacterial 
pathogens enter the gland and encounter cell types that release immune mediators 
including interleukin (IL)-8.  IL-8 has two membrane bound receptors: CXCR1 and 
CXCR2.  CXCR1 and CXCR2 are expressed on neutrophils and other cell types in other 
species but their expression is unknown in the bovine mammary gland.  To test this, 
mammary tissue samples from six Holstein dairy cows were subject to dual 
immunofluorescence with bovine specific CXCR1 and CXCR2 antibodies and cell type 
markers.  CXCR1 was expressed on alveolar epithelial cells, fibroblasts, and 
leukocytes.  CXCR2 expression was identified on alveolar epithelial cells and 
leukocytes.  Within the bovine CXCR1 sequence, key amino acids 122, 207, 245, 327, 
and 332 have the potential to influence receptor efficiency in ligand binding and/or 
downstream signaling effects.  Previous studies have linked some of these SNPs with 
mastitic phenotypes.  The three SNPs (VWHRR, VWHKH, and AWQRR) were 
representative of 99% of the population.  To test the haplotype effect, forty Holstein 
dairy cows were haplotyped and experimentally challenged with Streptococcus uberis.  
Various infection responses were monitored until 28 days post challenge.  All cows with 
the VWHRR x VWHRR (n=5) and AWQRR x VWHRR (n=6) haplotype combinations 
required antibiotic treatment to clear infection whereas only 33.33% of VWHRR x 
VWHKH cows (n=7) required antibiotic therapy (p=0.0153).  Cows with a VWHRR 
homozygous haplotype displayed significantly higher milk (1.05 ± [plus or minus] 0.21) 
and mammary (1.23 ± [plus or minus] 0.17) scores and AWQRR x VWHRR cows had 
vi 
 
significantly lower milk (0.17 ± [plus or minus] 0.18) and mammary (0.41 ± [plus or 
minus] 0.14) scores then cows of all other haplotype combinations (p=0.0263 and 
p=0.0161 respectively) indicating levels of inflammation differed among haplotype 
combinations.   VWHRR homozygous cows also displayed significantly higher S. uberis 
bacteria counts (981.99 ± [plus or minus] 1947.05) then cows of any other haplotype 
combination (p=0.0348).  Somatic cell counts (p=0.1399) and milk yield (p=0.6126) 
were not influenced by haplotype.  Coupling this knowledge together indicates the 
critical role this receptor-ligand complex plays in a cow’s ability to resist mastitis.    
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Chapter I: Introduction 
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Mastitis, an inflammation of the mammary gland, is an ongoing issue in the dairy 
industry that costs producers billions of dollars annually (NMC 2005).   Bacteria most 
frequently cause mastitis.  Once bacteria enter the gland, encountered cells generate 
danger signals and release cytokines; among them interleukin-8 (IL-8), growth related 
oncogene-γ (GRO-ɣ ), and epithelial cell neutrophil-activating peptide-78 (ENA-78).  
Interleukin-8 is released by a variety of cell types in response to stressors such as: 
reactive oxygen species (ROS), bacterial fragments, and other pro-inflammatory 
cytokines (DeForge et al. 1993; Grob et al. 1990).  Interleukin-8 is responsible for three 
key immune related functions: stimulating the migration of other cell types (Grob et al. 
1990; Takata et al. 2004), regulation of host cell survival (Kettritz et al. 1998; 
Shamaladevi et al. 2009), and modulation of chemokine and cytokine profiles.   
Moyes (2009) revealed S. uberis induced mastitis causes a 1054-fold increase in 
IL-8 gene transcription.  Experimental challenge with S. uberis, E. coli and Serratia 
marcescens demonstrated increased concentrations of IL-8 in the milk in comparison to 
uninfected glands (Bannerman et al. 2004; Riollet et al. 2000; Shuster et al. 1997).  
Direct infusion of IL-8 into the mammary gland increased the number of leukocytes, 
antibodies and serum albumin in the milk suggesting IL-8 impacts several immune 
related functions in the gland (Watanabe et al. 2008). 
Interleukin-8 has two specific, membrane-bound receptors, CXCR1 and CXCR2.  
CXCR1 is expressed on neutrophils, other immune cells (Del Rio et al. 2001; Grob et al. 
1990; Holmes et al. 1991; Lee et al. 1992; Moser et al. 1991), human mammary stem 
cells, and breast cancer cells (Ben-Baruch 2003).  CXCR2 is also expressed on 
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immune cells, especially neutrophils (Ahuja and Murphy 1996; Grob et al. 1990; Lee et 
al. 1992; Moser et al. 1991; Sprenger et al. 1994) as well as endothelial cells, and some 
epithelial cells (Wislez et al. 2006).  In bovine mammary tissue, it is unknown which cell 
populations express these two receptors.  Because of the increased concentrations of 
IL-8 observed in mastitic glands and IL-8’s association with immune related functions, a 
more thorough understanding of the cell types expressing these receptors is critical for 
understanding mammary gland responses to infection.   
The bovine CXCR1 gene has several single nucleotide polymorphisms (SNPs) 
that our lab has associated with mastitis (Youngerman et al. 2004).  The key SNP 
demonstrating this association was at position +735, but several others also were 
identified (+365, +621, +980, +995) (Table 1).  The +365 SNP, located on the first 
extracellular loop, involves a T to C switch, a valine to alanine amino acid change, has 
close proximity to the ligand binding site and the ability to affect ligand binding and 
affinity (Leong et al. 1994; Monteclaro and Charo 1996; Pighetti et al. 2012).  The +621 
SNP induces an early stop codon truncating the receptor and removing its ability to 
perform internal signaling upon ligand binding if it is expressed.  The +735 SNP has 
been linked to increased cases of subclinical mastitis (Youngerman et al. 2004), 
decreased calcium signaling upon IL-8 binding (Rambeaud and Pighetti 2007), 
decreased neutrophil migration to the site of infection (Rambeaud and Pighetti 2005), 
decreased ROS generation from neutrophils to aid in bactericidal activities, and 
increased neutrophil survival (Rambeaud et al. 2006).  The +980 and +995 SNPs are 
located towards the intracellular C-terminus of the receptor.  Through specific 
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manipulation of the receptor sequence, the C-terminus including the +980 and +995 
SNPs was identified as playing a key role in binding of intermediates, migration, and 
receptor internalization and polymorphisms in the nucleotide sequence could impact 
these functions  (Raman et al. 2010).  Based on the bovine CXCR1 SNPs, amino acid 
haplotypes were developed and three (VWHKH, VWHRR, AWQRR) were 
representative of more than 99% of the sample Holstein population  (Pighetti et al. 
2012).  Cows with haplotypes that include fewer conserved amino acid changes may 
demonstrate decreased receptor functionality, making VWHRR the haplotype most 
likely to display the most decreased function.  This suggests that examining CXCR1 
haplotypes instead of the individual SNPs within the receptor’s gene may provide a 
more comprehensive understanding of a cow’s potential for fighting off mastitis and 
streamline efforts for genetic selection.   
 Based on IL-8 increases during multiple types of infection, known IL-8 receptors 
expressed on multiple cell types in other species, and the genetic association of CXCR1 
SNPs to disease susceptibility, I hypothesize that the IL-8 receptors, CXCR1 and 
CXCR2, will be present on more than just immune cells within the mammary gland and 
that cows with two copies of the specific CXCR1 haplotype, VWHRR, will display an 
increased susceptibility to developing mastitis following direct challenge.  The following 
two objectives will allow for the testing of the preliminary hypothesis: 
1. Evaluate types of cells expressing CXCR1 and CXCR2 in bovine mammary 
tissues. 
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2. Determine the association of CXCR1 haplotype on resistance to direct S. uberis 
challenge.  
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Table 1: CXCR1 SNP summary and location. 
 
SNP Base Change Amino Acid Change Location 
+365 TA VA 1st intracellular loop 
+621 GA WStop 2nd extracellular loop 
+735 GC QH 3rd intracellular loop 
+980 AG KR C-terminus 
+995 AG HR C-terminus 
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 Mammary Gland 
 The mammary gland is a complex and essential organ to bovines and other 
mammals where it serves two main functions: to provide the offspring nutrition for 
development/growth and immunity.  Offspring consuming milk secreted form the 
mammary gland are provided nutrition and immunity.  The milk contains essential fatty 
acids, amino acids, vitamin and minerals needed for calf growth and development 
(Armstrong 1959).  These nutrients are provided in a form that is highly digestible and 
absorbable to the still developing offspring.  Secreted milk also contains antimicrobial 
factors, immunoglobulins, lysozyme, complement, lactoferrin, and leukocytes, which are 
crucial components for the development of both gut and systemic immunity (Gopal and 
Gill 2000; Larson et al. 1980; Oviedo-Boyso et al. 2007).  These immune components 
are essential for bovine offspring survival because, unlike humans, dams do not pass 
antibodies to their offspring in utero (Larson et al. 1980).  Furthermore, immune 
components and cells present within the milk also aid the mammary gland itself in 
fighting off invading pathogens (Bishop et al. 1976; Oviedo-Boyso et al. 2007; Reiter 
1978; Reiter and Oram 1967).   
 The bovine udder is composed of four individual mammary glands separated by 
a layer of connective tissue lamellae (Dyce and Wensing 1971).  Within the parenchyma 
of each gland exists the secretory units which are termed alveoli (Figure 1) (Dyce and 
Wensing 1971).   The alveoli differ in size depending on their location in the gland, but 
are generally between 0.1 and 0.2 millimeters in diameter (Dyce and Wensing 1971).  
The alveoli include a layer of milk secreting epithelial cells, which will secrete milk into 
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the lumen of the alveoli (Figure 1).  Connecting the alveoli are a series of small 
excretory ducts (Dyce and Wensing 1971).  As you descend further down the gland, the 
ducts merge and increase in size until you reach lactiferous ducts (Dyce and Wensing 
1971).  The dozen or so lactiferous ducts then converge on the large cistern that 
connects to the ductus papillaris, or streak canal where milk is secreted (Dyce and 
Wensing 1971).  The mammary gland’s ductal and alveolar structures develop in a pad 
of adipose.  Cellular signals that aid in mammary gland differentiation and development 
are provided by the collective stromal tissue which includes the adipose pad (Neville et 
al. 1998).  By the time a cow reaches first parturition, the udder is fully developed with 
the mammary epithelium supported in stroma containing adipose cells (Figure 2) 
(Hovey et al. 1999; Neville et al. 1998).  The stroma also contains other cell types 
including fibroblasts and immune cells that can aid in development and differentiation 
and supports vascularization which is a necessity for the mammary gland (Neville et al. 
1998).  The supply of blood to the udder comes from the mammary artery, which runs 
from the pudendal trunk, along the abdomen and then to the udder.  From there, the 
blood flow continues in a series of smaller vessels to provide nutrients to the essential 
milk producing cells.  Endothelial cells construct the blood vessels within the gland, and 
are present in high numbers because milk production requires a high level of 
vascularization (Dyce and Wensing 1971).  Innervation of the bovine mammary gland is 
fairly uncomplicated.  The iliohypogastric and ilioinguinal ventral branches innervate the 
cranial glands and the skin of the udder whereas the caudal glands are innervated by 
the mammary branches of the pudendal nerve.  There is little innervation within the 
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gland itself with only sympathetic innervation to blood vessels and the teat sphincter 
(Peeters et al. 1949).   
There are many cell types present within the mammary gland that reside within 
several tissue types (Table 2, Table 3).  Epithelial cells are the primary component of 
the epithelium (epithelial cells, myoepithelial cells, and lumen) and comprise 70% of the 
cells in the parenchyma (Akers et al. 2006; Capuco et al. 1997).  Epithelial cells 
synthesize and secrete milk (Bauman et al. 2006).  Their main role is to remove 
nutrients from the neighboring blood capillaries and use the obtained nutrients to 
synthesize milk (Bauman et al. 2006).  In order to facilitate these nutrient transfer roles, 
epithelial cells are polarized, meaning the basal side has a much different role than the 
apical side.  The basal side, neighboring the basement membrane and capillaries, 
retrieves nutrients and the apical side, neighboring the alveolar lumen, synthesizes and 
secretes milk (Emerman and Pitelka 1977).  The endoplasmic reticulum is linked to the 
synthesis of milk proteins and the golgi apparatus to the production of lactose and the 
secretion of milk components in secretory vesicles (Bauman et al. 2006).  The number 
of mitochondria present within a given epithelial cell is in direct correlation with the 
energy needs of the cell during lactation (Veltri et al. 1990).  Furthermore, because 
epithelial cells line all the ductal and alveolar structures, they are often the first cell type 
encountered by invading pathogens and as such help initiate the immune response (De 
Schepper et al. 2008). 
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Figure 1: Diagram of an alveolus in a lactating mammary gland with surrounding 
myoepithelial cells and blood vessels.  (Anderson et al. 1985) 
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Figure 2: Developed murine mammary gland cross-section displaying epithelial cell (E) 
lined lumens (L) containing milk (M) surrounded by supporting adipocytes (A) (Jensen 
et al. 1991). 
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Table 2: Tissue types and structures present in bovine lactating gland (Akers et al. 
2006). 
 
Tissue Type Percentage 
Parenchyma 30 
Lumen 55 
Stroma 15 
 
 
 
Table 3: Approximate cell types present in bovine lactating mammary parenchyma with 
ranges dependent upon gland region (Capuco et al. 1997). 
 
Cell Type Percentage 
Endothelial cells 6.3 – 6.4 
Epithelial cells 70.7 – 69.7 
Fibroblasts 12.6 – 14.3 
Leukocytes 4.5 – 5.4 
Myoepithelial cells 5 
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Figure 3: Cross-section of a fully developed mammary gland characterized by 
completely developed alveoli with maximized lumen area and minimized stromal area 
(Howe et al. 1975). 
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Myoepithelial cells comprise about five percent of the (Table 2, Table 3) 
mammary parenchyma (Akers et al. 2006; Capuco et al. 1997) and are seen in tandem 
with epithelial cells where they lie between epithelial cells and the basement membrane.  
They attach to both the basement membrane and epithelial cells by hemidesmosomes 
and desmosomes, respectively (Glukhova et al. 1995).  Myoepithelial cells are 
associated with both alveolar and ductal epithelial cells.  Those associated with alveoli 
are discontinuous and form a basket-like network around the alveoli but still allow some 
alveolar epithelial cells direct contact to the basement membrane.  Those associated 
with ductal epithelial cells form a continuous layer that runs parallel to the long axis of 
the duct (Emerman and Vogl 1986; Gusterson et al. 1982).  Myoepithelial cells are 
responsible for the contraction of epithelial cells and the subsequent release of milk into 
the lumen of the alveoli and ducts (Bissell et al. 2003).  This action is completed by the 
actin and myosin that fills the cytoplasm of myoepithelial cells and is induced by 
oxytocin release associated with the initiation of milking stimulus (Gorewit et al. 1983; 
Lefcourt and Akers 1983).  Lastly, myoepithelial cells play a great role in the production 
of basement membrane components that include fibronectin, collagen IV, bioactive 
laminins, and nidogen (Gudjonsson et al. 2002; Gusterson et al. 1982; Warburton et al. 
1982). 
Fibroblasts are typically associated with the stroma portion of the parenchyma 
(Table 2), comprise 12.6 – 14.3% (Table 3) of the mammary gland, and have been 
linked to a variety of essential functions (Akers et al. 2006; Capuco et al. 1997).  They 
synthesize both collagen and extracellular matrix, which are major components of 
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connective tissues (Grinnell 2003).  They also play a critical role in wound healing.  
Fibroblasts are recruited to wound sites by chemoattractant factors and are then 
responsible for generating new extracellular matrix needed for cell ingrowth (Singer and 
Clark 1999).  Fibroblasts are intricately associated with the mammary stromal tissue 
(Hovey et al. 1999).  They are known to release one or more diffusible factors that 
preferentially select for epithelial cell growth and differentiation as well as alveolar 
morphogenesis in the mammary gland (Darcy et al. 2000).   
In the mammary gland, there are also lymphatic ducts that connect lymph nodes 
to the mammary gland and the blood supply.  Lymphatic ducts carry a yellow liquid, 
lymph, which drains into veins.  Lymph is primarily comprised of waste being funneled 
away from tissues and lymphocytes, a type of leukocyte (UK 2012).  Leukocytes or 
white blood cells are needed for defense of the mammary gland (Paape et al. 2002a).  
Shafer-Weaver et al. (1996) observed several populations of leukocytes in a healthy 
mammary gland (Table 4).  Cells expressing CD2 account for the largest fraction (53%) 
of leukocytes in the mammary gland.  They include all cells in T-cell lineage and natural 
killer cells.  This fraction can be broken down further into T-helper cells that are CD4 
positive, T-cytotoxic/suppressor cells that are CD8 positive, and γδ T-cells, each 
represents approximately 13, 31, and 9% of the leukocytes in the gland respectively.  B-
cells, those responsible for specific antibody presentation and secretion, account for 
35% of the leukocytes in the gland.  Cells expressing CD5 include: some T-cells, some 
B-cells, and T-cell precursors, thymocytes that together represent 41% of the 
leukocytes present.  Thus the majority of the leukocytes present in the mammary gland 
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are lymphocytes.  Another significant proportion (43%) of the leukocytes present are 
antigen presenting cells (APC), which express major histocompatibility complex II (MHC 
II).  Antigen presenting cells consist of B-cells, macrophages and dendritic cells.  
Macrophages and dendritic cells along with neutrophils, and some B-cells also express 
CD11, and these cells comprise 18% of the leukocytes in the gland.  Another marker, 
CD172a is unique to monocytes and granulocytes (neutrophils, basophils, and 
eosinophils), accounts for 25% of the leukocyte population, despite the attempted 
exclusion of these cell types using a ficoll gradient.  Lastly, non-T-cells, non-B-cells 
were identified via WC2 expression and represented only 4% of leukocytes in the 
mammary gland (Shafer-Weaver et al. 1996).   
The Shafer-Weaver study specifically looked at mononuclear cell populations 
and exempted granulocyte populations, making it necessary to evaluate the leukocyte 
populations within the mammary gland further.  Nickerson and Heald (1982) observed 
leukocytes present within both healthy and S. aureus infected quarters including 
populations of granulocytes (Table 5).  They discovered that within the healthy 
mammary quarter lymphocytes were the dominant population comprising 69.06% of the 
leukocytes, which is congruent with the Shafter-Weaver et al. (1996).  Antibody 
secreting plasma cells made up the next largest fraction representing 13.58% of the 
leukocytes.  The last fraction is made up of mast cells, monocytes/macrophages, and 
neutrophils and these are responsible for only 10.19%, 1.89% and 0.04% of the 
leukocytes in the healthy quarter respectively.  When a quarter is infected with S. 
aureus, the percentages of cells shift from primarily lymphocytes with minimal 
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granulocytes to approximately half lymphocytes and half granulocytes.  Lymphocytes 
and plasma cells still represent a large fraction at 40.5% and 17.38% respectively.  
However, neutrophils increase dramatically to account for 32.9% of leukocytes in the 
infected quarter.  The percent of monocytes/macrophages also increases to 5.39%, but 
the percent of mast cells decreases to 3.83%.  These results indicate that when the 
gland is healthy lymphocytes provide the primary defense mechanism, but under an 
infection state, granulocytes, especially neutrophils, become primarily responsible for 
gland defense (Nickerson and Heald 1982). 
Bovine milk from a healthy gland, like the gland tissue itself, contains many 
leukocyte populations (Table 5).  The predominant population is T-cells (88%) which 
includes CD4+ T-helper cells (20%), CD8+ T-cytotoxic/suppressor cells (50%), γδ T-
cells (3%) and some natural killer cells.  Unlike in the gland, B-cells do not comprise a 
significant portion of milk leukocytes, accounting for only 6%.  The remaining group are 
CD45R cells, which represent some T and B-cells, macrophages, and neutrophils; and 
is responsible for 17% of milk leukocytes (Taylor et al. 1994).  The CD45R group does 
not include all T-cells due to the fact that as T-cells mature and differentiate they shed 
their CD45 receptors (Mackay et al. 1990). 
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Table 4: Leukocyte populations present in a healthy, mid-lactation bovine mammary 
parenchyma following the use of a ficoll gradient to exclude the majority of granulocytes 
(Shafer-Weaver et al. 1996). 
 
Leukocyte (Marker Used) Percent Cells Staining Positive 
B-cells (surface IgM) 35 
T-cells & NK cells (CD2) 53 
T-helper cells (CD4) 13 
B-cells, T-cells, & Thymocytes (CD5) 41 
T-cytotoxic cells (CD8) 31 
DC cells, Monocytes, Macrophages, 
Neutrophils, and some B-cells (CD11) 
18 
Antigen-presenting cells (MHCII) 43 
Monocyte/Granulocyte (CD172a) 25 
γδ T-cells (WC1) 9 
Non-T, B-cells (WC2) 4 
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Table 5: Leukocyte populations present in healthy and S. aureus infected mammary 
quarters (Nickerson and Heald 1982). 
 
Leukocyte Percent Cells in Healthy 
Quarter 
Percent Cells in S. aureus 
Infected Quarter 
Lymphocytes 69.06 40.50 
Plasma cells 13.58 17.38 
Neutrophils 0.04 32.90 
Monocytes/Macrophages 1.89 5.39 
Mast cells 10.19 3.83 
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Table 6: Leukocyte populations present in milk secretions from a healthy, lactating 
bovine mammary gland (Taylor et al. 1994). 
 
Leukocyte (Marker Used) Percent Cells Staining Positive 
B-cells (WC3) 6 
T-cells (CD2) 88 
T-helper cells (CD4) 20 
T-cytotoxic cells (CD8) 50 
γδ T-cells (WC1) 3 
Leukocytes (B-cells, subset of T-cells, 
Macrophages, Neutrophils) (CD45R) 
17 
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T-cells are the predominate leukocyte present in both healthy mammary 
parenchymal tissue and milk (Shafer-Weaver et al. 1996; Taylor et al. 1994).  T-cells 
play a role in eliciting an immune response against invading pathogens and token 
antigens (Kaufmann 1988).   T-cells are subdivided into two categories, αβ T-cells and 
γδ T-cells (Pardoll et al. 1987).  Those of the αβ subtype can be further divided into T-
helper (CD4+) cells and T-cytotoxic (CD8+) cells (Zlotnik et al. 1992).  Both T-helper 
cells and T-cytotoxic cells recognize token antigens in the context of MHC on APCs 
using a T-cell receptor (TCR) that has α and β chains and can be present in a variety of 
tissue types (Fowlkes and Pardoll 1989).  Once a T-helper cell recognizes antigen it 
releases a plethora of cytokines that aid activating cytotoxic T-cells, dendritic cells and 
macrophages, as well as the maturation of B-cells into effector or plasma cells (Zlotnik 
et al. 1992).  Cytotoxic T-cells are responsible for destroying infected and/or damaged 
cells.  The infected and/or damaged cells are recognized by cytotoxic cell T-cell 
receptor (TCR) interaction with antigen that is presented by MHC I (Park et al. 1993).  
T-cells expressing the γδ TCR are typically less predominant than those expressing the 
αβ TCR (Hein and Mackay 1991), and unlike αβ T-cells do not always require antigen 
presentation via MHC II to recognize antigen (Mackay et al. 1988).  The γδ T-cells are 
typically involved in recognizing antigens of a lipid nature or bacterial danger signals 
such as degrading cells (Mackay and Hein 1991).   
B-cells are another cell type that is highly present within the mammary 
parenchyma (Shafer-Weaver et al. 1996).  The primary role of B-cells is to make 
antibodies specific to one recognized antigen (Clark and Ledbetter 1994).  B-cells can 
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also serve to present antigens via MHC II (Cassell and Schwartz 1994).  Naïve B-cells 
circulate in healthy blood and tissue and once they are exposed to antigen, they 
become one of two distinct subclasses: a plasma cell or a memory cell.  Plasma cells 
are responsible for the secretion of specific antibodies against a single antigen in order 
to tag the invading pathogen and make it more recognizable for the immune system to 
destroy, as well as prevent binding to host cells (Clark and Ledbetter 1994).  Memory 
cells also are specific to a single antigen and are formed from a single activated B-cell 
during the initial infection.  Memory cells live for long periods of time and allow for a 
more rapid response to specific antigen upon sequential infection (Clark and Ledbetter 
1994).   
Monocytes are critical to mammary gland health but are present in low numbers 
due to the fact that once they migrate into the tissue they differentiate into macrophages 
or dendritic cells.  They are however, always present in the blood supply and upon 
activation are quickly recruited to the sites of infection.  Monocytes migrate from the 
blood supply into tissues via adhesions to endothelial cells lining blood vessels 
neighboring infection sites.  Selectins expressed on endothelial cells weakly bind 
glycoproteins on activated monocytes and allow them to roll across the vessel wall and 
slow enough to bind more strongly via surface integrins that have counter-receptors 
expressed on endothelial cells.  After this tight bond is established monocytes enter 
tissue via extravasation (Imhof and Aurrand-Lions 2004). Once at the site of infection 
they differentiate into macrophages and dendritic cells that can both engulf and destroy 
pathogens via phagocytosis (Gordon and Taylor 2005).  Monocytes also enter tissue in 
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the manner described above to replace resident macrophages as needed when there is 
not an infection present (Gordon and Taylor 2005).   
Macrophages are considered the ever-present sentinels of the mammary gland.  
Their primary function is to maintain tissue homeostasis and defense through clearing 
senescent cells, repairing damage (Gordon 1986; Gordon 1998), phagocytizing 
pathogens,  and subsequently killing pathogens to eliminate the threat they pose to the 
gland (Outteridge and Lee 1981).  Macrophages also take on the role of antigen 
presenting, displaying antigens from phagocytized bacteria in conjunction with MHC II to 
make them more readily recognized by T-helper cells (Politis et al. 1992).  Several 
studies have also demonstrated the importance of macrophages in perpetuating the 
immune response by the release of chemoattractants (interleukin-1 (IL-1) and ENA-78) 
that are important for neutrophil and T-cell responses (Allmann-Iselin et al. 1994; 
Splitter and Everlith 1989; Ziegler et al. 1984). 
 Dendritic cells share several similarities with macrophages.  They too can 
phagocytize and kill invading pathogens as well as present antigens to T-helper cells via 
MHC II (Banchereau and Steinman 1998).  Dendritic cells also stimulate clonal 
proliferation, differentiation into effector or memory cells, and the secretion of cytokines 
upon T-helper cell binding to MHC II (Paape et al. 2002b).   They are also known to 
produce cytokines like tumor necrosis factor alpha (TNF-α) and interleukin-12 (IL-12) to 
perpetuate the immune state, help recruit other immune cells such as neutrophils and 
macrophages, and enhance the cytotoxic abilities of natural killer cells and T-cytotoxic 
cells (Hope et al. 2003).  Furthermore, dendritic cells play a crucial role in activating the 
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adaptive immune response.  Once matured, dendritic cells can present antigen directly 
to T-helper cells which in turn interact with antigen primed B-cells to initiate the cascade 
that develops memory plasma B-cells (Steinman and Hemmi 2006).  Dendritic cells can 
be found in alveolar structures, interalveolar spaces, and in the epithelium within the 
bovine mammary gland (Maxymiv et al. 2012).  However, they are distinct from 
macrophage populations.  Macrophages express MHC class II, CD11chi, and CD14hi 
whereas dendritic cells show MHC class II, CD11chi, CD14lo, and CD205 marker 
expression.  These differences in receptor expression make the two cell populations 
distinguishable via multicolor immunohistochemistry and flow cytometry assays 
(Maxymiv et al. 2012). 
 Neutrophils are cells that are recruited into tissues by the presence of infection.  
If no infection exists, their numbers will be relatively low, but if an infection is present, 
their numbers will show a marked increase.  Neutrophils are recruited to the site of 
infection via chemoattractants and they enter tissues in much the same manner as 
described for monocytes (Burg and Pillinger 2001).  More precise information about 
neutrophils is provided in the section titled ‘Immune Mediators’. 
Mastitis 
Mastitis or mammary gland inflammation, an ongoing issue in the dairy industry, 
costs the dairy industry billions of dollars annually (NMC 2005).  Losses come in a 
variety of forms, some of which include: discarded milk from infected cows, antibiotic 
therapies, replacement of culled cows, and extra labor costs for time spent treating and 
caring for mastitic cows (Akers and Nickerson 2011; Fetrow 2000; Jones et al. 1994; 
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Short and Lawlor 1992). However, the greatest loss is attributed to decreased milk 
production in cows that are subclinically and clinically infected (Akers and Nickerson 
2011; Fetrow 2000; Jones et al. 1994; Short and Lawlor 1992).  A number of factors can 
influence the probability or susceptibility of a cow contracting mastitis and includes: age, 
parity, stage of lactation, pathogen type, genetics, season, and climate (Hogan and 
Smith 1987; Oliver and Mitchell 1983; Ruegg 2003; Smith et al. 1985).   Instance of 
mastitis increases with parity, the more offspring a cow has the more likely it becomes 
that she will contract mastitis (Ruegg 2003).  Cows not actively being milked or in early 
lactation are more prone to developing mastitis.  Cows in late stages of lactation have a 
significantly decreased instance of mastitis (Oliver and Mitchell 1983).  Furthermore, 
warm temperatures and moist climates favor the growth of most pathogens, increasing 
their total numbers and thus the probability they will come into contact with a cow and 
cause mastitis (Hogan and Smith 1987).  Because of the variety  of factors, there is 
diversity in the instances mastitis across herds and breeds of dairy cattle.  Herds are 
known to be have incidence of mastitis in 20-50% of their cows (Wilson et al. 1997) and 
breeds that have been subjected to selection methods for increased milk yield like 
Holstein dairy cows tend to be associated with increased mastitis (AIPL 2013).  
Furthermore, mastitis continues to be one of the primary reasons for decreased 
productive life (AIPL 2013).   
Mastitis has two types of causes: non-infectious or infectious.   Non-infectious 
causes are incidents such as blunt trauma to the udder.  These traumas arise from 
kicks from another cow or collision with objects in the cows’ housing environment.  
Infectious causes are much more diverse and caused by a microorganism entering the 
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gland and establishing infection.  Some infectious agents are: algae, yeasts, and 
viruses, but the cases of mastitis that result from these infectious agents are a very 
small fraction compared to those cases that arise from bacteria. 
Bacteria are present everywhere in the cows’ environment.  Making good 
management practices absolutely crucial to the control and prevention of mastitis (Gill et 
al. 1990; Jayarao and Wolfgang 2003; Ruegg 2003).  During machine milking, bacteria 
present on or within the milking unit can easily be transferred into the teat end due to 
the relaxed state of the teat sphincter during the milking process (Hogan and Smith 
1987).  Bacteria can also be introduced during the administration of intramammary 
infusions, such as those used during the dry off (non-lactating) period (Hogan and Smith 
1987).  Another common means of entrance is directly from the environment.  Soil in 
pastures, bedding, and pre/post milking sanitation processes all are possible sources of 
infection (Bushnell 1984; Hogan et al. 1989; Pankey and Drechsler 1993).  Once the 
bacteria gain entrance to the mammary gland, they benefit in a variety of ways.  The 
gland itself is protection from other environmental factors that could be detrimental to 
the bacteria.  The gland is warm, providing the bacteria with a temperature closer to 
their optimum growth and replication temperatures.  The milk present within the gland 
provides an energy source for bacterial growth.  Thus, once bacteria are inside the 
mammary gland, they are in an environment that allows them to not only survive but 
potentially thrive. 
Mastitis bacterial pathogens are highly prevalent and hundreds of causative 
species have been isolated.  Mastitis has two basic classifications: clinical and 
subclinical.  Clinical cases have symptoms such as inflammation (redness, heat, 
31 
 
swelling, and pain), dramatically increased somatic cell counts (SCC), atypical or 
decreased milk production, abnormal or lack of activity, fever and weight loss 
(Youngerman et al. 2004a).  Subclinical cases produce less severe symptoms where 
visual changes in the udder are not observed, but somatic cell counts are still elevated, 
just not to the degree of a clinical incidence (Youngerman et al. 2004a).  Subclinically 
infected cows cause the greatest loss of profit to farmers with a 10 to 12% decrease in 
milk production associated with a single subclinically infected quarter over the length of 
a single lactation (Akers and Nickerson 2011).  The panel of symptoms observed with a 
particular case of mastitis can often be tied to the type of pathogen.  Incidences of E. 
coli mastitis are typically of rapid onset with altered and decreased milk production and 
in some cases fever and lethargy and will clear in a few days (Smith and Hogan 1993).  
However, S. aureus mastitis typically start similarly to E. coli but lead to subclinical 
cases that show some alteration and reduction in milk production and can persist for the 
life of the cow (Sutra and Poutrel 1994). 
These bacterial pathogens can be broken into two groups: environmental and 
contagious (Smith 1983).  Environmental pathogens include a larger array of bacteria 
that are present everywhere in the surroundings of the dairy herd (Smith et al. 1985).  
Herds that demonstrate a pattern of increased clinical mastitis instance, particularly in 
spring and summer months when the weather is hot and wet, often indicate the 
establishment of environmental pathogens present in the mammary gland (Smith et al. 
1985).  Common environmental pathogens include Streptococcus uberis, Streptococcus 
agalactiae Streptococcus dysgalactiae, coliform bacteria (Escherichia coli, Klebsiella 
spp.), coagulase-negative Staphylococci (CNS), and Enterobacter spp. (Hogan and 
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Smith 1987; Jayarao and Wang 1999; Jayarao and Wolfgang 2003).  Because of their 
prevalence, they are often used as models to study mastitis.   
Streptococcus uberis is an environmental pathogen causing approximately 14-
26% of all subclinical and clinical mastitis cases (Jayarao et al. 1999; Phuektes et al. 
2001).  It is the most commonly isolated pathogen during the dry period (Bramley 1984; 
Bramley and Dodd 1984; Oliver 1988).  In vitro studies have indicated that within two 
hours after S. uberis exposure to epithelial cells, S. uberis closely associates with 
epithelial cell microvilli (Matthews et al. 1994).  Further observation revealed pedestal 
formation indicating adherence of S. uberis with the epithelial cell membrane (Matthews 
et al. 1994).  This adherence occurs between S. uberis and epithelial cells as well as 
extracellular matrix proteins (Almeida et al. 1996).  Glycosaminoglycans facilitate 
adhesion (Almeida et al. 1999).  Glycosaminoglycans are covalently bound to the 
abundant membrane proteins proteoglycans and often used by  bacteria for attachment 
(Liang et al. 1992).  Fang et al. (1999) identified a molecule specific to S. uberis, 
lactoferrin-binding molecule that aided in bacterial attachment.  Lactoferrin, a milk 
protein, when added to in vitro mammary epithelial cell cultures facilitated the binding of 
S. uberis to epithelial cells (Fang and Oliver 1999).  Mammary epithelial cells bind 
lactoferrin (Rejman et al. 1994), that in turn facilitates internalization of S. uberis into 
bound epithelial cells (Fang et al. 2000).  This molecule was later re-named S. uberis 
adhesion molecule (SUAM) and the development of SUAM specific antibodies that 
decreased S. uberis adherence (Almeida et al. 2006).  This evidence suggests that 
SUAM may be a novel candidate in the development of alternative treatments or 
preventative measures for S. uberis based mastitis. 
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Inflammatory Cytokines Linked to Infection 
 The innate immune system gives the mammary gland the ability to combat a 
variety of invading pathogens.  Due to its relatively non-pathogen-specific methods of 
pathogen recognition, the innate system provides a rapid response even upon first 
exposure (Oviedo-Boyso et al. 2007).  Initial recognition stems from pathogen-
associated molecular patterns (PAMPs), which help to initiate the immune response.  
Bacterial cells are distinct from mammalian cells allowing for specific immune 
responses.  Their cell walls are comprised of components like lipopolysaccharide (LPS), 
peptidoglycan and lipoteichoic acid that are considered PAMPs (Bannerman et al. 
2004b; Han et al. 2003).  PAMPs are recognized by a class of membrane-bound 
receptors termed toll-like receptors (TLRs) (Rosenberger and Finlay 2003).  TLR4 binds 
bacterial components such as LPS, polypeptides and host associated compounds such 
as fibrinogen, heat-shock proteins, polypeptides that are released under stressful 
conditions (Beutler 2004; Takeuchi et al. 2000).  Another TLR, TLR2 recognizes gram-
positive associated molecules such as peptidoglycan and lipoteichoic acid (Takeuchi et 
al. 2000).  TLR5 detects flagella that are characteristic of many species of motile 
bacteria and TLRs 3 and 9 bind dsRNA and dsDNA associated with endosomes 
respectively (Rosenberger and Finlay 2003; Wagner 2004).  In addition to TLRs, 
chemical components of bacteria can be recognized by complement molecules, 
formylated peptide receptors, mannose-binding lectins, and ficolins (Akira and Takeda 
2004; Fournier and Philpott 2005; Rooijakkers et al. 2005; Rosenberger and Finlay 
2003).  Once bacteria are recognized by these avenues, they induce the production of 
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immune mediators, especially cytokines, from local cell populations in the mammary 
gland (Bannerman et al. 2004b). 
 Cytokines are considered key immune mediators and some are associated with 
the inflammatory state, including TNF-α, IL-1, and interleukin-6 (IL-6).  Bacteria enter 
the mammary gland and can interact with both epithelial cells and macrophages.  The 
binding of bacterial PAMPs to TLRs induces production and secretion of TNF-α.  TNF-α 
stimulates the recruitment and bactericidal activities of neutrophils, in addition to 
perpetuating the inflammatory state by aiding in the production of IL-1, IL-6, and 
arachidonic acid metabolites (Atkinson et al. 1990).  Following experimental challenge 
with S. uberis, increases in milk TNF-α were observed approximately 72 h post infusion 
(Bannerman et al. 2004a).  Furthermore, Moyes et al. (2009) demonstrated that during 
S. uberis mastitis, TNF-α transcripts were increased 45-fold, which most likely 
contributes to increased levels of TNF-α protein.  TNF-α is the first cytokine to increase 
in milk following experimental challenge with E. coli and Serratia marcescens.  Peak 
TNF-α concentrations were reached between 12 and 18 post bacterial inoculation and 
persisted for up to 48 h (Bannerman et al. 2004a; Bannerman et al. 2004b; Riollet et al. 
2000; Shuster et al. 1997).  Increased levels of TNF-α are also seen in sera and milk 
after infection with other coliforms including: E. coli, Klebsiella oxytoca, Pseudomonas 
aeruginosa, and Enterobacter spp. (Nakajima et al. 1997).  LPS injection into the gland 
has yielded conflicting results.  After direct infusion of LPS  into the gland, no significant 
increases in TNF-α were witnessed (Shuster et al. 1993).  Contrastingly, increased 
TNF-α has been linked to endotoxic shock in acute cases of mastitis suggesting there 
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may be an intermediate process that could tie TNF-α and mastitis together (Havell 
1989; Persson Waller et al. 2003; Ślebodziński et al. 2002). 
Interleukin-1, like TNF-α, can perpetuate the inflammatory state and stimulate 
neutrophil migration and killing through stimulating the release of other mediators such 
as IL-8 (Bannerman et al. 2004b; Boulanger et al. 2003; Stein et al. 2003).  Production 
of IL-1 is induced following recognition of bacterial presence by TLRs on macrophages 
and epithelial cells (Oviedo-Boyso et al. 2007; Yamanaka et al. 2000; Zhang and 
Issekutz 2002).  IL-1 is known to be present in milk during the early stages of S. uberis, 
E. coli, and S. aureus infections (Bannerman et al. 2004a; Bannerman et al. 2004b; 
Oviedo-Boyso et al. 2007; Riollet et al. 2000; Yamanaka et al. 2000; Zhang and 
Issekutz 2002).  Increases in concentrations of IL-1 begin shortly after increases in 
TNF-α (Riollet et al. 2000; Shuster et al. 1997).  Following S. uberis mastitis, there is a  
14-fold increase in IL-1 transcripts, which could contribute to increased levels of IL-1 
protein (Moyes et al. 2009).  LPS injection into the mammary gland produced increased 
IL-1 concentrations more rapidly, displaying increased levels of IL-1 as early as 2.5-4 h 
post injection (Shuster et al. 1993).  Increased levels of IL-1 were not observed in milk 
following challenge with Serratia marcescens until 96 h post infusion of the bacteria 
(Bannerman et al. 2004a). Combined, these results suggest IL-1 plays a significant role 
in S. uberis and E. coli mastitis but not Serratia marcescens mastitis. 
Interleukin-6 is synthesized primarily from macrophages and epithelial cells that 
have interacted with bacteria directly or with bacterial toxin via TLRs (Rainard and 
Riollet 2003; Zhang and Issekutz 2002).  IL-6 is involved in the massive influx of 
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neutrophils into the mammary gland.  IL-6 binding to endothelial cells induces the 
release of interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) to recruit 
neutrophils and cause increased expression of adhesion molecules to aid in neutrophil 
extravasation (Romano et al. 1997).  Moyes et al. (2009) demonstrated that during S. 
uberis mastitis, IL-6 transcripts were increased 430-fold, which may contribute to 
increased levels of IL-6 protein witnessed during mastitis incidence.  IL-6 typically 
follows increased TNF-α and IL-1 concentrations at approximately 14 h post E. coli 
infection (Nakajima et al. 1997; Shuster et al. 1997).  LPS injection resulted in a rapid 
increase in IL-6 concentrations occurring as early as 2.5 h (Shuster et al. 1993).  
Increased levels of IL-6 are also seen in sera and milk after infection with other 
coliforms including: E. coli, Klebsiella oxytoca, Pseudomonas aeruginosa, and 
Enterobacter spp. (Nakajima et al. 1997).  Together, this suggest that the degree of IL-6 
response is dependent on the causative agent. 
ELR+ Chemokines 
A family of glutamic acid-leucine-arginine+ (ELR+) chemokines includes: growth 
related oncogene (GRO)-α, GRO-β, GRO-γ, epithelial-derived neutrophil-activating 
peptide-78 (ENA-78), granulocyte chemotactic protein-2 (GCP-2), neutrophil-activating 
peptide-2 (NAP-2), and interleukin-8 (IL-8). The nomenclature of ELR+ chemokines are 
summarized in Table 7.  These chemokines share a C-X-C motif in their structures and 
are linked to both inflammatory and reparative functions (Miller and Krangel 1992; 
Oppenheim et al. 1991).  An important three amino acid sequence, E-L-R, directly prior 
to the first cysteine residue of the C-X-C motif is linked to their ability to induce or inhibit 
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migration of neutrophils (Clark-Lewis et al. 1993; Clark-Lewis et al. 1995; Hébert et al. 
1991).   
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Table 7: List of standardized and common names of ELR+ chemokines. 
 
Standardized Name Common Names 
CXCL1 GRO-α, NAP-3 
CXCL2 GRO-β, MIP-2 
CXCL3 GRO-γ, MIP-2b 
CXCL5 ENA-78 
CXCL6 GCP-2 
CXCL7 NAP-2, PPBP 
CXCL8 IL-8, GCP-1, NAP-1, NCF 
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Growth Related Oncogenes 
Growth related oncogene-α (GRO-α, NAP-3, CXCL1) is expressed by two cell 
types: epithelial cells, and macrophages.  Bovine mammary epithelial cells secrete 
basal levels of GRO-α at all times (Lahouassa et al. 2007).  E. coli stimulation increases 
GRO-α concentrations steadily until at least 24 h post exposure (Lahouassa et al. 
2007).  Upon stimulation with S. aureus, levels increase slightly by three h post 
exposure and return to basal levels by 24 h (Lahouassa et al. 2007).  Unstimulated 
human mammary epithelial cells (Maheshwari et al. 2003), cultured human bronchial 
epithelial cells (Marshall et al. 2001) and human vaginal epithelial cells (Peterson et al. 
2005) increase GRO-α production in response to infection.  Upon stimulation of lung 
alveolar macrophages with E. coli endotoxin, GRO-α is released (Goodman et al. 1998).  
These indicate that GRO-α is released naturally and in response to a variety of bacterial 
stimuli. 
Growth related oncogene-β (GRO-β, MIP-2, CXCL2) also is expressed by 
epithelial cells and macrophages.  After stimulation with E. coli, cultured bovine 
mammary epithelial cells release GRO-β and continue for at least 24 h (Lahouassa et 
al. 2007).  S. aureus stimulation resulted in increases similar to those observed by E. 
coli stimulation but did not surpass E. coli stimulation concentrations (Lahouassa et al. 
2007).  Similarly, GRO-β is released from unstimulated human mammary epithelial cells 
(Maheshwari et al. 2003), S. aureus stimulated human vaginal epithelial cells (Peterson 
et al. 2005), and E. coli endotoxin stimulated lung alveolar macrophages (Goodman et 
al. 1998). 
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Growth related oncogene-γ (GRO-γ, MIP-2b, CXCL3) is expressed by several 
cell types such as epithelial cells, macrophages, monocytes, and neutrophils.  Bovine 
mammary epithelial cells constitutively express GRO-γ during uninfected and infected 
states (Rainard et al. 2008), as do human mammary epithelial cells (Maheshwari et al. 
2003).  S. aureus stimulated human vaginal epithelial cells also increase GRO-γ 
concentrations (Peterson et al. 2005).  Furthermore, bacterial endotoxin and/or 
inflammatory cytokines, TNF-α and IL-1 stimulate GRO-γ release from lung alveolar 
macrophages, monocytes, and neutrophils (Goodman et al. 1998; Haskill et al. 1990; 
Iida and Grotendorst 1990). 
The GRO chemokines have the ability to induce neutrophil migration (Geiser et 
al. 1993; Haskill et al. 1990; Lahouassa et al. 2007; Rainard et al. 2008; Youngs et al. 
1997).  Specifically, GRO-γ had been identified as the largest recruiter of neutrophils 
from bovine milk during both uninfected and infected states (Rainard et al. 2008).  
These chemokines also have been associated with events subsequent to neutrophil 
migration such as: neutrophil exocytosis, neutrophil shape changes, increases in 
intracellular Ca++ levels, and neutrophil respiratory burst (Ahuja and Murphy 1996; 
Geiser et al. 1993; Lahouassa et al. 2007; Rainard et al. 2008).  GRO-γ is unique in 
possessing some effect on basophils, having the capability to induce chemotaxis and 
increases in intracellular Ca++ concentrations (Geiser et al. 1993).  Overall, the GRO 
chemokines possess properties very similar to that of IL-8 
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Epithelial-derived Neutrophil-activating Peptide-78 
Epithelial-derived neutrophil-activating peptide-78 (ENA-78, CXCL5), as its name 
suggests, was first discovered in an epithelial cell culture line (A549) (Walz et al. 1991), 
but also is released from macrophages and monocytes (Allmann-Iselin et al. 1994).  
Basal levels of ENA-78 are released from cultured epithelial cells (A549) at all times 
(Walz et al. 1991).  Increased release of ENA-78 was not induced by LPS or other 
bacterial endotoxins, but it is massively induced by pro-inflammatory cytokines such as 
TNF-α and IL-1 (Walz et al. 1991).   
Like its family members, ENA-78 is primarily known for its ability to attract 
neutrophils.  In bovines, ENA-78 was first characterized from lung tissue (Allmann-Iselin 
et al. 1994).  The potency of ENA-78 as a neutrophil chemoattractant was similar to that 
of IL-8 at most concentrations (0.1-100nmol/L) (Allmann-Iselin et al. 1994; Walz et al. 
1991).  However, IL-8’s function was approximately ten times higher at the more 
elevated concentrations (100 and 1000nmol/L) (Allmann-Iselin et al. 1994; Walz et al. 
1991).  Bovine ENA-78 also was comparable to IL-8 at inducing neutrophil aggregation 
(Allmann-Iselin et al. 1994).  However, ENA-78 activated the release of intracellular 
Ca++ more efficiently than low concentrations of IL-8 (1nmol/L) but comparable at higher 
concentrations (Allmann-Iselin et al. 1994; Walz et al. 1991).  ENA-78 also mediates 
elastase release by neutrophils in a similar dose dependent manner (Walz et al. 1991).  
Lastly, ENA-78 was able to induce a shape change in neutrophils similar ( i.e.: fast, 
prolonged, dose dependent) to IL-8  (Allmann-Iselin et al. 1994).  All together, these 
data suggest ENA-78 has comparable capabilities to IL-8, but is not as potent. 
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Neutrophil-activating Peptide-2 
 Neutrophil-activating peptide-2 (NAP-2,PPBP, CXCL7) is a 70 amino acid 
cleavage product of the platelet α-granule component of platelet basic protein (PBP) 
and its precursor, connective tissue-activating peptide-III (CTAP-III) (Walz and 
Baggiolini 1989).  The cleavage action of a monocyte released protease generates 
NAP-2 from its platelet derived precursor (Walz and Baggiolini 1990).   The release of 
NAP-2 is often in response to stimuli such as E. coli LPS (Walz and Baggiolini 1989).  
Like its family members, NAP-2 can induce elastase release, increased levels of 
intracellular Ca++, neutrophil chemotaxis, and neutrophil exocytosis (Loetscher et al. 
1994; Walz et al. 1989).  The NAP-2 induced changes were considered completely 
independent of its precursors, PBP and CTAP-III, because neither of the precursors 
were capable  (Walz et al. 1989).  NAP-2 also increases microvascular permeability to 
aid in neutrophil extravasation (Van Osselaer et al. 1991).  However, NAP-2 is 
considered a less potent activator than IL-8 but still capable of recruiting neutrophils and 
aiding in their migration to the site of infection (Walz et al. 1989). 
Interleukin-8 
Interleukin-8 (IL-8, GCP-1, NAP-1, NCF, CXCL8) is an immune-related 
chemokine.  Interleukin-8 is released in response to a variety of cell stressors such as 
reactive oxygen species, bacterial fragments, and pro-inflammatory cytokines 
(Baggiolini and Clark-Lewis 1992; Bautista and Spitzer 1990; DeForge et al. 1992; 
DeForge et al. 1993; Grob et al. 1990; Matsushima and Oppenheim 1989; Seitz et al. 
1991).  An activator responsible for IL-8 release is ROS.  Reactive oxygen species 
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include superoxides, peroxides, and hydroxyl radicals.  ROS are produced as 
intermediates or byproducts of normal cellular functions (Liu et al. 2002) including 
bacteria initiated leukocyte  phagocytic processes (Bautista and Spitzer 1990).  
Superoxide anions (O2
-) are converted to hydrogen peroxide (H2O2) which then can be 
broken down to a hydroxyl radical (OH·).  Each by product has been associated with 
high levels of damage in surrounding tissues (Halliwell 1991).  Increased concentrations 
of ROSs directly influence the production and release of IL-8 through the regulation of 
gene expression (DeForge et al. 1993).  Furthermore, LPS stimulated whole blood 
treated with ROS scavengers leads to  a significant reduction in the amount of IL-8 
present within blood with no reduction in cell viability or the pro-inflammatory cytokines 
TNF-α, IL-1, or IL-6 (DeForge et al. 1992). 
Bacterial fragments such as LPS, upon binding to TLR4 activate IL-8 release 
(Bautista and Spitzer 1990; Grob et al. 1990; Seitz et al. 1991).  Pro-inflammatory 
cytokines such as TNF-α, IL-1, and IL-6, which are released in response to infection 
induce IL-8 release (Baggiolini and Clark-Lewis 1992; Grob et al. 1990; Matsushima 
and Oppenheim 1989; Seitz et al. 1991).  All of these stressors (reactive oxygen 
species, bacterial fragments, and pro-inflammatory cytokines) are indicators of an 
inflammatory state, which provides a link between the inflammatory state and IL-8. 
After IL-8 is released, it is responsible for key immune responses.  Perhaps the 
most well documented function of IL-8 is its ability to stimulate migration of specific cell 
types.  This ability allows recruitment of leukocytes, especially neutrophils, to the site of 
infection and allows the host to be more efficient in fighting off infection.  Once bound to 
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the neutrophil, IL-8 induces three main changes in neutrophils.  First, a conformational 
change allows adherence to endothelial cells which is essential for migration out of the 
blood vessel to infected tissues (Baggiolini and Clark-Lewis 1992).  Second, exocytosis 
of soluble storage proteins from secretory vesicles and granules cause increased 
expression of adhesion molecules such as CD11b,c and CD18 that are essential for 
adhesion to endothelial cells (Baggiolini and Clark-Lewis 1992).  Congruently, 
macrophages are activated to produce and release cytokines as well as enhance 
macrophage phagocytosis of IgG-opsonized bacteria  (Soehnlein et al. 2008), and 
opsonization of pathogens like Staphylococcus aureus (Heinzelmann et al. 1998).  Last, 
activation of NADPH-oxidase helps generate ROS used to combat foreign pathogens at 
the site of infection (Baggiolini and Clark-Lewis 1992).   
Another function of IL-8 is the regulation of host cell survival, typically by 
prohibiting apoptosis and extending the life-span of neutrophils.  This would allow them 
to fight infections longer (Kettritz et al. 1998; Shamaladevi et al. 2009).  Interleukin-8 
also modulates chemokine and cytokine profiles to aid in perpetuating the inflammatory 
state (Soehnlein et al. 2008).  Interleukin-8 has two specific membrane bound 
receptors, CXCR1 and CXCR2, which are G-protein coupled receptors (Ahuja and 
Murphy 1996; Lee et al. 1992; Murphy 1994).  Upon IL-8 binding to its receptors, it 
activates G-protein coupled responses.  Downstream effects of G-protein signaling 
include two main signaling pathways: cyclic adenosine monophosphate (cAMP) and 
phosphatidylinositol.  Both of these pathways are responsible for a wide variety of 
biological responses that range from hormone to inflammatory signaling (Baggiolini and 
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Clark-Lewis 1992).  Furthermore, gene products influenced by E. coli based mastitis are 
those associated with G-protein coupled signaling (Buitenhuis et al. 2011; Mitterhuemer 
et al. 2010; Rinaldi et al. 2010).  IL-8 is a key component of the immune response that 
amplifies the pro-inflammatory signals released from the site of infection.  
Several different cell types including: epithelial cells, endothelial cells, fibroblasts, 
macrophages, dendritic cells, and neutrophils produce IL-8 in order for IL-8 to respond 
to stressors and induce the necessary downstream effects.  Cultured primary mammary 
epithelial cells and MAC-T cells demonstrated IL-8 release in response to E. coli LPS, 
E. coli, and S. aureus stimulation (Boudjellab et al. 1998; Lahouassa et al. 2007).  
Further examination with the MAC-T cell line revealed LPS binding of TLR4 caused the 
release of TNF-α and IL-1, which causedIL-8 release (Boudjellab et al. 2000; Fitzgerald 
et al. 2007).  The ability of epithelial cells to initiate the immune response is critical 
because they are often the first cell type encountered by invading bacteria.  Cultured 
human endothelial cells (Strieter et al. 1989a) and fibroblasts (Strieter et al. 1989b) also 
release IL-8 in response to LPS, IL-1, and TNF-α stimulation.  Bovine macrophages, the 
sentinels of the mammary gland, release IL-8 in response to a variety of pro-
inflammatory cytokines, bacterial fragments and toxins, and phagocytosis (Craven 
1983).  Lastly, neutrophils, although commonly viewed as primarily responding to IL-8 
released from other cells, can release IL-8 themselves in response to phagocytosis, 
LPS, and human/bovine lactoferrin.  This perpetuated neutrophil recruitment to the site 
of infection via subsequent binding to the membrane bound receptors, CXCR1 and 
CXCR2, expressed on neutrophils  (Bazzoni et al. 1991; Shinoda et al. 1996). 
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Upon infection within the mammary gland an increase in IL-8 was observed.  
Moyes et al. (2009) revealed that S. uberis induced mastitis caused a 1054-fold 
increase in IL-8 gene transcription, making it the most significantly altered gene in this 
study.  Experimental intramammary challenge with E. coli also showed a significant 
increase in IL-8 mRNA production compared to non-challenged glands (Buitenhuis et al. 
2011).  A second E. coli study demonstrated IL-8 mRNA was up-regulated 120-fold in 
infected mammary tissue (Mitterhuemer et al. 2010).  In similar findings, the IL-8 gene 
transcripts persisted for at least 24 h post E. coli infusion (Rinaldi et al. 2010).  
The increase in gene transcripts most likely contributes to the increase in protein 
expression observed in following studies.  Experimental challenge with S. uberis 
produced a sustained elevation in milk IL-8 levels for over 96 h post infusion 
(Bannerman et al. 2004a).  The increased levels of IL-8 associated with E. coli mastitis 
follow the same pattern as S. uberis, with an initial surge in whey.  IL-8 levels steadily 
decrease as the infection clears (Riollet et al. 2000; Shuster et al. 1997).  In contrast, 
when S. aureus mastitis was experimentally induced, IL-8 was not detected in the whey.  
This pattern was consistent across six cows and suggests that pathogen specificity or 
pathogen action may play a significant role in the cytokines released (Riollet et al. 
2000).  S. marcescens intramammary challenge produced a rapid spike in IL-8 which 
tapered off after about 24 h (Bannerman et al. 2004a).  Together, these data suggest IL-
8 is a critical early indicator of an infection state within the mammary gland. 
Watanabe at el. (2008) showed that injecting recombinant bovine IL-8 into the 
mammary gland produced a wide variety of effects.  The most significant effects were a 
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dramatic increase in the number of somatic cells, specifically neutrophils, present in the 
mammary gland and in the milk, increased concentration of antibodies, and the amount 
serum albumin in milk in comparison to a gland not infused with IL-8.  This suggests 
that IL-8 has the capability to alter the integrity of the milk-blood barrier allowing 
increased concentrations of somatic cells and serum proteins to enter the milk and 
dramatically increase the neutrophil population within the mammary gland (Watanabe et 
al. 2008).   
CXCR1 and CXCR2 
 The CXCR1 and CXCR2 genes are located on chromosome 2q and each 
consists of a coding region of approximately 1000bp (Pighetti and Rambeaud 2006).   
The CXCR1 gene is located on chromosome 2q, on the opposite strand, and close to 
the q telomere, whereas the CXCR2 gene is located on chromosome 2q but closer to 
the centromere (Pighetti and Rambeaud 2006).  In addition to their close proximity in 
the genome, the receptors’ share a high degree of homology.  The mRNA transcripts 
display 95% homology in their nucleotide sequences and the completed peptides share 
84% homology, including 100% homology in the last, 50 amino acids of the C-terminus 
(Lahouassa et al. 2008; Pighetti and Rambeaud 2006).   
Despite the homology between the two receptors, CXCR1 and CXCR2 display 
differential binding characteristics.  CXCR1 has two ligands, IL-8 and the rarely seen 
granulocyte chemotactic protein-2 (GCP-2), whereas CXCR2 is more promiscuous.  
CXCR2 binds IL-8 with high affinity, like CXCR1, but it also binds GRO-α, β, γ, ENA-78, 
and NAP-2, which are all functionally similar to IL-8 (Ahuja and Murphy 1996; LaRosa et 
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al. 1992; Lee et al. 1992).  Both receptors are part of the G-protein-linked seven 
transmembrane domain receptor family and possess the characteristic three 
intracellular loops (Murphy 1994).  The extracellular amino-terminus of the receptor 
dictates ligand binding specificity (LaRosa et al. 1992).  The intracellular carboxyl-
terminus initiates receptor internalization and cellular signaling pathways via its coupled 
G-proteins (Ben-Baruch et al. 1995; Richardson et al. 2003).   
CXCR1 and CXCR2 receptors are expressed on neutrophils (Ahuja and Murphy 
1996; Grob et al. 1990; Lee et al. 1992; Li and Gordon 2001; Paape et al. 2002a; 
Sprenger et al. 1994).  The expression of CXCR1 has also been documented on other 
immune related cells including: dendritic cells (Sallusto et al. 1998), natural killer cells 
(Berahovich et al. 2006), CD4+ T-cells (Gasser et al. 2006), and CD8+ T-cells (Takata 
et al. 2004).  Less has been documented about their expression on non-immune cell 
populations.  However, CXCR1 has been shown to be expressed on human mammary 
stem cells (Ben-Baruch 2003) and endothelial cells (Murdoch et al. 1999), as well as 
several cancer cell types including: breast cancer cells (Ben-Baruch 2003; Charafe-
Jauffret et al. 2009), prostate cancer cells (Shamaladevi et al. 2009), and malignant 
melanoma cells (Gabellini et al. 2009).  The other receptor, CXCR2 is expressed on 
endothelial cells and some epithelial cells (Dwinell et al. 1999; Miller et al. 1998; Wislez 
et al. 2006).  In bovine mammary tissue, it is unknown which cell populations express 
these two receptors and thus which cell types can respond to IL-8 and its functionally 
similar family members. 
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These receptors have been studied in a variety of species.  The bovine CXCR1 
and CXCR2 genes have significant amounts of synergy with the corresponding genes in 
other species including humans and mice (Grosse et al. 1999; Lahouassa et al. 2008; 
Pighetti and Rambeaud 2006; Sonstegard et al. 1997).  Within the human CXCR1 gene, 
several SNPs have been identified and some have been associated with susceptibility 
to inflammatory diseases (Kato et al. 2000; Renzoni et al. 2000).  A goal of the cattle 
industries is to improve general herd health using genetic selection processes.  In 
efforts to identify potential marker candidates, studies hunted for SNPs within immune 
related genes, including the genes for CXCR1 and CXCR2.  A study by Grosse et al. 
(1999) identified four key SNPs in the CXCR1 gene.  These SNPs were originally 
reported in CXCR2 but, close homology between the sequences of the bovine CXCR1 
and CXCR2 receptors caused confusion with the original annotation within public 
databases (Lahouassa et al. 2008; Pighetti and Rambeaud 2006).  The majority of 
papers concerning bovine CXCR1 that were published prior to the discovery of the 
incorrect annotation in 2006 refer to CXCR2 when they are actually CXCR1.  Further 
examination of these SNPs revealed their presence within both Angus and Herford 
breeds as well as their crossbreeds (Heaton et al. 2001).  Upon examining these same 
SNP profiles in Jersey and Holstein dairy cattle breeds, all four SNPs were observed 
and a fifth SNP was identified (Youngerman et al. 2004a).  Leyva-Baca et al. (2008) 
also looked at CXCR1 SNPs (c.-20-1648, c.-20-1586, c.+291, and c.+735) and the 
relationship to mastitis in Holstein dairy cows.  Of these identified SNPs, only c.-20-
1586 showed an association with high somatic cell scores (SCS) and was limited to the 
first and second lactations (Leyva-Baca et al. 2008).  
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Our lab further examined the CXCR1 gene in dairy cattle and determined an 
association between mastitis and certain SNPs in the bovine CXCR1 gene.  Originally, 
five SNPs were identified: +612, +684, +777, +858, and +861 (Youngerman et al. 
2004b).  However, all were synonymous substitutions except +777, which induced a 
glutamine to histidine change (Youngerman et al. 2004b).   Subsequent studies 
discovered the +777 SNP was linked to increased subclinical and clinical cases of 
mastitis (Youngerman et al. 2004a).  These initial studies led to a more comprehensive 
examination of polymorphisms in the CXCR1 gene and the naming conventions 
changed to reflect the Human Genome Variation Society Guidelines (Table 8).  The 
study discovered a total of 11 polymorphisms within the coding region: +291, +365, 
+570, +621, +735 (formerly +777), +816 (formerly +858), +819 (formerly +861), +980, 
+995, +1008, and +1068 (Pighetti et al. 2012).  Of these, six are synonymous, four 
(+365, +735, +980, +995) induced amino acid changes and one (+621) induced an 
early stop codon (Pighetti et al. 2012).  The +365 SNP is located on the first intracellular 
loop and has close proximity to the G-protein coupled receptor that allows for the signal 
cascade (Leong et al. 1994).  Similarly, the +735 SNP is located on the third 
extracellular loop and has been linked to a variety of downstream effects of IL-8 binding 
that have been studied by our lab (Rambeaud et al. 2006; Rambeaud and Pighetti 
2007; Rambeaud and Pighetti 2005; Youngerman et al. 2004a).   
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Table 8: A partial list of bovine CXCR1 SNPs indicating current and previous naming 
conventions (Pighetti et al. 2012). 
 
Standardized SNP Positiona SNP Position in Prior Publications 
c.-20-1648 -1830 
c.-20-1586 -1768 
c.+291 +344 
c.+365  
c.+621  
c.+735 +777 
c.+816 +858 
c.+819 +861 
c.+980  
c.+995  
 
 
a Based on Human Genome Variation Society Guidelines in reference to the cDNA and 
the position relative to the transcription start site within the genome. 
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The +735 SNP involves a G to C switch on the gene that results in a glutamine to 
histidine change in the amino acid structure of the CXCR1 receptor.  Cows with the CC 
genotype have displayed increased cases of subclinical mastitis (Youngerman et al. 
2004a), decreased calcium signaling upon IL-8 binding (Rambeaud and Pighetti 2007), 
decreased neutrophil migration (Rambeaud and Pighetti 2005), ROS generation from 
neutrophils to aid in bactericidal activities (Rambeaud et al. 2006) and increased 
neutrophil survival (Rambeaud et al. 2006).  Other studies have demonstrated only a 
tendency for the +735 SNP to be associated with SCS that are typically seen in 
conjunction with incidences of subclinical mastitis (Beecher et al. 2010; Goertz et al. 
2009; Leyva-Baca et al. 2008).  These differences are most likely due to sample size, 
since the Youngerman (2004a) study had a small sample size (n=88) and the Beecher 
(2010), Goertz (2009), and Leyva-Baca (2008) studies had large sample sizes (n=246, 
n=749, n=338 respectively).  We hypothesize that cows with the CC genotype at 
CXCR1 c.+735 are at a disadvantage for fighting off infections due to the impaired 
immune functions.  Cows that have the GG genotype displayed normal levels of 
neutrophil survival, migration, ROS generation and internal calcium signaling, and have 
been associated with a lower instance of subclinical mastitis (Youngerman et al. 2004a).  
Those cows expressing the heterozygous genotype (GC) display a mixture of these 
responses and thus have functions that lie between normal and impaired levels of ability 
(Rambeaud et al. 2006; Rambeaud and Pighetti 2007; Rambeaud and Pighetti 2005; 
Youngerman et al. 2004a).   
SNPs +980 and +995 occur close to the C-terminus of the receptor (Pighetti et al. 
2012).  The +980 position has been shown to influence ligand binding, migration, as 
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well receptor internalization of the CXCR2 receptor (Raman et al. 2010).  This 
information is relevant due to the fact that the C-termini of the bovine CXCR1 and 
CXCR2 receptors are virtually identical (Lahouassa et al. 2008).  Lastly, the +621 SNP 
that induces an early stop codon is located within the second intracellular loop of the 
receptor.  Regardless of whether this switch causes partial or no receptor expression, 
the +621 SNP has potential to influence function of the CXCR1 receptor. 
Individual tagSNPs were combined to form amino acid based haplotypes (Table 
9) (Pighetti et al. 2012).  A tagSNP represents a group of SNPs in high linkage 
disequilibrium or non-random allele association, increasing the probability that SNPs will 
be inherited together.  Three amino acid haplotypes (VWHKH, VWHRR, AWQRR) 
represented more than 99% of the sample bovine population (n=88) (Pighetti et al. 
2012).  Knowledge of the potential effects of each SNP mutation allows for the 
conclusion that VWHRR homozygous cows may be impaired in their abilities to 
effectively respond to bound ligand compared to the other haplotype combinations.  The 
existence of three dominant haplotypes within the sample population suggests looking 
at haplotypes instead of individual SNPs within the receptor’s gene may provide a more 
comprehensive understanding of the cow’s potential to fight off mastitis.  Haplotype 
selection may also streamline efforts for genetic selection by increasing the number of 
identifying SNPs could allow for more specific selection of cows with a better genetic 
background relative to CXCR1. 
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Table 9: Relationships among CXCR1 c.+735 allele, tagSNP haplotype, and amino acid 
haplotype (Pighetti et al. 2012). 
 
+735 Allele 
(Former 
+777) 
tagSNP Haplotype Nucleotide 
Haplotype 
Amino Acid 
Haplotype 
735 +621+735+816+980 365-621-735-980-995 122-206-245-327-332 
C GCCA TGCAA VWHKH 
G AGCG CAGGG AX 
C GCAG TGCGG VWHRR 
G GGCG CGGGG AWQRR 
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Interleukin-8 receptor expression in bovine mammary tissue. 
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Abstract 
Mastitis is an ongoing issue in the dairy industry, which often results from a 
variety of immune related responses to bacteria in the mammary gland. Many immune 
responses are mediated by interleukin-8 (IL-8) and its receptors CXCR1 and CXCR2. 
Exposure of the mammary gland to bacteria causes the release of IL-8.  Subsequent 
binding of IL-8 to its receptors induces immune responses related to host cell survival, 
migration and chemokine/cytokine production. These receptors are typically regarded 
as being present on immune cells with an emphasis on neutrophils.  Within the bovine 
mammary gland we hypothesize CXCR1 expression on immune cells and epithelial 
cells and CXCR2 expression on immune cells, epithelial cells, and endothelial cells 
based on research conducted in other species.  To evaluate CXCR1 and CXCR2 
expression in bovine mammary gland we used dual immunofluorescence on mammary 
tissue sections from 6 Holstein dairy cows in early (5-6d days in milk (DIM)), mid (59-
99d DIM), and late (>250d DIM) lactation. Results demonstrate CXCR1 and CXCR2 
have different patterns of expression.  We discovered both CXCR1 and CXCR2 
expressed natively in the bovine mammary gland.  CXCR1 is expressed by epithelial 
cells, some fibroblasts and 10-50% of leukocytes, whereas CXCR2 is present on 
epithelial cells and 5-30% of leukocytes.  These results indicate that multiple cell types 
in the mammary gland express receptors for IL-8 and are capable of responding to IL-8 
released in the environment. Greater knowledge of how these cell populations respond 
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to IL-8 binding its receptors within the mammary gland could create novel treatment 
targets for mastitis. 
Introduction 
 Mastitis costs the dairy industry billions of dollars in lost profits annually (NMC 
2005).  Mastitis is typically caused by bacteria entering the mammary gland.  Once 
within the gland, bacteria encounter a variety of cell types, mainly epithelial cells 
because they comprise about 70% of mammary gland parenchyma (Capuco et al. 
1997).  These cells can initiate the immune response when bacterial components such 
as lipopolysaccharide (LPS) bind pathogen recognition receptors such as TLR4 on the 
cell surface of encountered cells.  Upon TLR4 engagement many proinflammatory 
cytokines are released including TNF-α and IL-1 (Beutler 2004; Takeuchi et al. 2000).  
Interaction of TNF-α and IL-1 with their specific receptors causes the subsequent 
release of a second round of immune mediators, which can include ELR+ chemokines 
(Boudjellab et al. 2000; Fitzgerald et al. 2007). 
The ELR+ chemokines include GRO-α (CXCL1), GRO-β (CXCL2), GRO-γ 
(CXCL3), ENA-78 (CXCL5), GCP-1 (CXCL6), NAP-2 (CXCL7) and IL-8 (CXCL8) (Grob 
et al. 1990; Lahouassa et al. 2007; Rainard et al. 2008; Walz et al. 1991; Walz et al. 
1989).  The ELR+ chemokines initiate several immune functions necessary for 
combating infection.  This includes chemotaxis of neutrophils to the site of infection, 
increased expression of adhesion molecules on endothelial cells, neutrophil respiratory 
burst, and neutrophil shape change, which is needed for extravasation from blood into 
tissues (Allmann-Iselin et al. 1994; Baggiolini and Clark-Lewis 1992; Geiser et al. 1993; 
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Grob et al. 1990; Lahouassa et al. 2008; Loetscher et al. 1994).  ELR+ chemokines also 
mediate host cell survival allowing cells to live longer and fight off infections by 
decreasing spontaneous apoptosis (Kettritz et al. 1998).  Lastly, chemokine/cytokine 
profiles are altered by ELR+ chemokines.  This aids in perpetuating the inflammatory 
state and the continued increase in neutrophil chemotaxis and survival (Soehnlein et al. 
2008). 
The ELR+ chemokines bind two specific receptors, CXCR1 and CXCR2.  The 
CXCR1 receptor binds both IL-8 and GCP-1 with high affinity, but GCP-1 is rarely 
observed in vivo (Ahuja and Murphy 1996).  The CXCR2 receptor binds all ELR+ 
chemokines mentioned in the prior paragraph, but has the highest affinity for IL-8 (Ahuja 
and Murphy 1996; Lee et al. 1992).  These two receptors are expressed on neutrophils 
but the expression of these receptors on other cell types is less well studied (Ahuja and 
Murphy 1996; Grob et al. 1990; Lee et al. 1992; Li and Gordon 2001; Paape et al. 2002; 
Sprenger et al. 1994).  In other species CXCR1 expression has been demonstrated on 
endothelial cells, mammary stem cells, dendritic cells, natural killer cells, CD4+ T-cells, 
CD8+ T-cells, and eosinophils.   CXCR2 has more limited expression including  
endothelial cells, epithelial cells, and eosinophils (Ben-Baruch 2003; Berahovich et al. 
2006; Gasser et al. 2006; Park et al. 2010; Petering et al. 1999; Sallusto et al. 1998; 
Takata et al. 2004).  Furthermore, receptor expression has been tied to a variety of 
cancers (i.e.:  malignant melanomas, prostate cancer, and breast cancer) where they 
contribute to prolonged cell survival and metastasizing (Ben-Baruch 2003; Gabellini et 
al. 2009; Shamaladevi et al. 2009). 
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In the bovine mammary gland, little is known about CXCR1 and CXCR2 
expression.  In this study we evaluated CXCR1 and CXCR2 expression in lactating 
bovine mammary tissue through the use of dual immunofluorescence with antibodies 
specific to bovine CXCR1, CXCR2 and cell type markers. 
Materials and Methods 
Animal and Tissue Selection 
 Tissue samples were obtained from n=6 Holstein dairy cows, two in early 
lactation (5-6d days DIM), two in mid lactation (59-99d DIM), and two in late lactation 
(248-337d DIM).    From each cow, tissue samples were taken from a healthy quarter 
and a quarter infected with Streptococcus uberis, a common mastitis causing pathogen.  
Early lactation cow samples were obtained from cows sacrificed as part of a USDA-
NIFA (2011-67015-30168) funded challenge study at East Tennessee Research and 
Education Center (ETREC; Knoxville, TN) and the mid and late lactation samples were 
obtained from our collaborator Dr. John Lippolis at the USDA-NADC (Ames, IA). 
Verification of Antibody Specificity 
Dot Blot to Evaluate Specificity of CXCR1 and CXCR2 to Peptides 
Antibodies were developed in rabbits against specific amino acid peptides of the 
N-termini of bovine CXCR1 (PTEDYDYSPCEISTET) and CXCR2 (MAETKFTSNIEGFC) 
which were conjugated to KLH to improve immunogenicity (21st Century Biochemicals, 
Inc., Marlboro, MA).  These specific amino acid segments were synthesized (Peptide 
2.0, Inc., Chantilly, VA and 21st Century Biochemicals, Inc., Marlboro, MA) and used to 
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verify antibody specificity between CXCR1 and CXCR2 on a PVDF membrane using a 
dot blot assay.  From initial peptide stocks of 1mM, peptides were diluted 1:40 (25µM), 
1:200 (5µM), and 1:1000 (1µM) in PBS and applied to the PVDF membrane using a 
vacuum.  A control (no peptide) also was included.  The membranes then were blocked 
using PBS + 1% non-fat dry milk + 0.1% Tween-20 for 20 min at room temperature.  
After a series of two washes in PBS, the desired primary antibody: rabbit anti-bovine 
CXCR1, CXCR2, or pre-immunization sera (1:1000) was applied to the membrane and 
allowed to incubate at room temperature for 30 min with shaking.  The membrane was 
washed twice in PBST [PBS + 0.1% Tween-20] and once in PBS to remove excess 
primary antibody.  Next, stabilized goat anti-rabbit HRP-conjugate secondary antibody 
(Pierce 34095, Rockford, IL; 1:5000) was incubated with the membrane for 30 min at 
room temperature with shaking.  Lastly, after another two washes in PBST and one in 
PBS, the membrane was developed with a 1:1 solution of peroxide buffer and 
luminol/enhancer solution (Pierce 34095, Rockford, IL).  Pictures were taken using 
Alpha Innotech Fluorchem imaging equipment and software.  Various combinations of 
CXCR1 and CXCR2 antibodies and peptides were tested together using this method to 
ensure that cross-binding was not observed.  Results indicate that cross-binding does 
not occur between antibody and pre-bleed combinations, CXCR1 antibody and CXCR2 
peptide, or between CXCR2 antibody and CXCR1 peptide suggesting antibody 
specificity (Figure 4). 
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Figure 4: Dot blots indicating bovine CXCR1 and CXCR2 antibody specificity.  (A) 
Specific CXCR1 antibody binds CXCR1 peptide with increasing concentrations of 
peptide.  (B) CXCR2 antibody does not bind CXCR1 peptide.  (C) CXCR1 peptide does 
not interact with CXCR1 pre-bleed sera.  (D) Specific CXCR2 antibody binds CXCR2 
peptide with increasing concentrations of peptide.  (E) CXCR1 antibody does not bind 
CXCR2 peptide.  (F) CXCR2 peptide does not interact with CXCR2 pre-bleed sera. 
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Bovine Mammary Gland Protein Lysate Preparation 
Approximately 100mg of frozen tissue was lysed in modified RIPA buffer (50mM 
TrisHCl pH 7.4, 150mM NaCl, 0.1% TritonX100, 5mM EDTA supplemented with DTT 
(1mM) and  inhibitors (Roche, 04693159001, Indianapolis, IN) by use of a rotor-stator 
homogenizer (3 bursts of 10  s) followed by sonication (3 bursts of 10 s) on ice. 
Resulting lysates were cleared by centrifugation at 15,000g for 3 min at 4°C and stored 
at -80oC.  Lysates from mouse liver and mammary tissue of all six cows were prepared.  
For each lysate, concentration was determined using a BCA Protein Assay (Pierce, 
Rockford, IL).  (Performed by Leszek Wojakiewicz)  
Western Blot  
Twelve percent SDS-PAGE gels with electrophoretically resolved protein lysates 
(50µg per lane) were blotted onto PVDF membrane using Trans-Blot SD (Bio-Rad, 
Hercules, CA).   MagicMark (Bio-Rad, Hercules, CA) was used as the molecular weight 
marker.  Semi-dry blotting was performed at constant current of 60mA for 1 h in CAPS 
(for catode 1X CAPS + 1%SDS; for anode 1X CAPS +15% methanol) buffer system. 
Detection of both CXCR1 and CXCR2 was carried out using custom affinity purified 
polyclonal rabbit antibodies (IgG) raised against specific peptides described earlier (21st 
Century Biochemicals) with original concentrations of 0.019mM for anti-CXCR1 and  
0.0098mM for anti-CXCR2. Prior to probing, blots were pre-blocked overnight at 4oC in 
TBST buffer supplemented with 10% casein blocking reagent (Roche, 11921673001, 
Indianapolis, IN). Next they were incubated in TBST buffer with 5% casein blocking 
reagent and primary antibody at 1:200 dilution at room temperature on a rocking 
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platform, then washed three times for 15 min with cold TBST at room temperature on a 
rocking platform. This was followed by detection of primary antibody using a Femto 
detection kit (Pierce, 34095, Rockford, IL). Blots were incubated with goat anti-rabbit 
antibody conjugated to HRP (TBST, 5% casein blocking reagent, antibody at 1:10,000) 
for 45 min at room temperature on a rocking platform, washed three times for 15 min in 
cold TBST and incubated in 1mL of combined HRP substrate and enhancer for 1 min. 
Freshly air-dried blots were imaged on Alpha Innotech Fluorchem imaging equipment 
and software with exposure times ranging from 1-20 min. For experiments using primary 
antibodies pre-blocked with specific peptides, solutions containing those antibodies 
supplemented with 20µM specific peptide or equal volume of water, but without casein 
blocking reagent were pre-incubated 30 min at room temperature on a nutator, then 
supplemented with blocking reagent and used in protocol outlined above.  (Performed 
by Leszek Wojakiewicz) 
Preparation of Tissue Section Slides 
 Using plastic molds, approximately 1cm by 1cm pieces of mammary tissue 
stored at -80°C were embedded in optimal cutting temperature compound (OCT) using 
liquid nitrogen to the solidify mold.  The tissue containing molds then were sliced to 6µm 
thick using a cryostat and placed on frost plus slides (Fisher 12-550-18, Pittsburg, PA).  
Slides were immediately fixed in -20°C acetone for 5 min and allowed to air dry.  Slides 
were stored frozen at -80°C until time of staining. 
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Dual Immunofluorescence Staining 
Slides were first brought to room temperature for 30 min, then fixed in -20°C 
acetone for 5 min, washed twice in PBST and then blocked using a sera blocking 
solution (PBS + 5% goat serum (Thermo Scientific, Rockford, IL) + 5% horse serum 
(Oxoid, Basingstoke, NH)) for 20 min with shaking.  Next, slides were washed once in 
PBST and then incubated with the primary antibody combination (Table 10) overnight 
(15-18 hours) at 4°C with shaking in a mini-humidifier.  Slides that received pre-
immunization sera or no primary antibody also were included to serve as negative 
controls.  Following overnight incubation, slides were washed three times in PBST and 
then incubated with secondary antibody combinations (Table 10) for 1 hour at room 
temperature, in the dark, with shaking in a mini-humidifier.  Again, slides were washed 
three times in PBST and then counterstained for 5 min with 4,6-diamidino-2-
phenylindole (DAPI) (300nM) (Invitrogen D3571, Grand Island, NY) at room 
temperature and washed twice more in PBST.  A drop of mounting media (Vector H-
1000, Burlingame, CA) was applied and a coverslip added followed by clear nail polish 
to seal the slide.  Microscopy was performed using a Leica SP2 laser scanning confocal 
microscope and corresponding software.  Images were taken of one area representative 
of the entire tissue section.  Percentages of positive staining cells were determined by 
visual count of cells present within each image and averaged across all cows. 
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Table 10: Primary and secondary antibodies used for dual immunofluorescence. 
 
Name Cell Type Source Isotype Species Dilution 
CD45 
(CACTB51A) 
Leukocytes VMRD, Inc. 
0491-0506 
IgG2a Murine 1:500 
Connexin-43 
(2/Connexin-
43) 
Myoepithelial 
cells 
BD 
Transduction 
Laboratories 
610062 
IgG1 Murine 1:500 
Pan- 
Cytokeratin 
(AE1/AE3) 
Epithelial 
cells 
Santa Cruz 
Biotechnology 
SC-81714 
IgG1 Murine 1:30 
Vimentin 
(Vim3B4) 
Fibroblasts Dako M7020 IgG2a Murine 1:100 
CXCR1 -- 21st Century 
Biochemicals 
Sera Rabbit 1:1000 
CXCR2 -- 21st Century 
Biochemicals 
Sera Rabbit 1:1000 
DyLight 549 
Goat-anti-
rabbit IgG 
(H+L) (GAR) 
-- Vector DI-1549 IgG Goat 1:1000 
DyLight 488 
Horse-anti-
mouse IgG 
(H+L) (HAM) 
-- Vector DI-2488 IgG Horse 1:1000 
 
  
85 
 
Results 
 Western blots of mammary whole cell lysates from each cow were used to 
determine the specificity of bovine CXCR1 and CXCR2 antibodies.  The CXCR1 blot 
displayed multiple positive staining bands in both bovine mammary gland and mouse 
liver (Figure 5 A).  However, a band between 50 and 60kDa was present for bovine 
mammary gland but absent for mouse liver indicating CXCR1 specificity for this band in 
bovine mammary gland.  The specific CXCR1 band between 50 and 60kDa was present 
across all cows with some variation in level of expression based on band density 
(Figure 5 B).  The CXCR2 blot contained multiple bands but one band at approximately 
60kDa was more dominant and observed for both bovine mammary gland and mouse 
liver lysates (Figure 6 A).  Blocking of antibodies with CXCR2 peptide decreased or 
eliminated this band indicating this band was specific and cross-reacted with mouse 
CXCR2.  The dominant CXCR2 band was present across all cows (Figure 6 B). 
CXCR1 is expressed on mammary epithelial cells (Figure 7 C, D).  CXCR1 
staining (red) is concentrated basally on alveolar epithelial cells, and epithelial staining 
(green) is concentrated apically on alveolar epithelial cells.  Dual expression is observed 
on alveolar epithelial cells from both uninfected and infected tissues (Figure 7 C, D).  
Myoepithelial cells, often observed as green punctate cells, did not express CXCR1 as 
indicated by Figure 7 E, F.  CXCR1 is expressed on some fibroblasts in both infected 
and uninfected tissues (Figure 7 G, H), where dual expression is observed throughout 
the stromal regions between alveolar structures. Fibroblast expression of CXCR1 was 
not consistent across cows or infection status with 2/6 cows expressing CXCR1 on 
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fibroblasts in uninfected quarters and 4/6 cows expressing CXCR1 on fibroblasts in 
infected quarters (Table 11). Mammary leukocytes express CXCR1 with approximately 
10-50% of leukocytes showing dual expression (Figure 7 I, J). 
CXCR2 also is expressed on mammary epithelial cells (Figure 8 C, D).  CXCR2 
(red) is observed surrounding alveolar epithelial cells and concentrated to bright edges 
(Figure 8 C, D; Figure 9).  The bright edges sometimes represent one alveolar 
epithelial cell and at other times represent a string of adjoining alveolar epithelial cells 
(Figure 9).  The epithelial marker (green) demonstrates the same staining pattern.  
Overlaid images representing both markers display yellow staining indicating dual 
expression (Figure 8 C, D).  Neither myoepithelial cells (Figure 8 E, F) nor fibroblasts 
(Figure 8 G, H) display CXCR2 in uninfected or infected gland tissue.  Leukocytes 
express CXCR2 in both uninfected and infected quarters with approximately 5-30% of 
leukocytes demonstrating dual expression (Figure 8 I, J). 
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Figure 5: CXCR1 western blots results demonstrating specific binding of the bovine 
CXCR1 antibody for band between 50 and 60kDa.  (A) Depicts duplicate lanes of 
bovine mammary whole cell lysate (boMG) or mouse liver whole cell lysate (moLiv).  
One boMG and one moLiv lysate was suspended in buffer with 1% SDS to ensure 
complete membrane breakdown and to optimized receptor binding.  The boxed band 
between 50 and 60kDa present in boMG is absent from moLiv indicating specificity of 
CXCR1 for this band only in bovines. (B) Demonstrates band of interest between 50 
and 60kDa is present in mammary whole cell lysates from each of the six cows used 
with some variation in level of expression based on band density. 
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Figure 6: CXCR2 western blots results demonstrating specific binding of the bovine 
CXCR2 antibody for band at approximately 60kDa.  (A) Depicts blots with lanes 
containing marker, bovine mammary whole cell lysate (boMG), or mouse liver whole cell 
lysate (moLiv).  The boxed bands at approximately 60kDa in lanes 2 and 3 are removed 
via specific peptide blocking of antibody in lanes 5 and 6 and shows affinity for both 
bovine and mouse CXCR2. (B) Demonstrates band of interest at approximately 60kDa 
is present in mammary whole cell lysates from each of the six cows used. 
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Figure 7: CXCR1 expression in bovine mammary gland.  Red corresponds to CXCR1 
expression and green corresponds to cell specific markers.  Yellow indicates dual 
expression of both red and green markers and is indicated by arrow heads (◄).   
Negative controls receiving only secondary antibody, (A) GAR and (B) HAM, 
demonstrated no staining.  CXCR1 was expressed on alveolar epithelial cells in both 
(C) uninfected quarters and (D) infected quarters.  CXCR1 was not observed on 
myoepithelial cells in (E) uninfected or (F) infected quarters.  CXCR1 was observed on 
some fibroblasts in both (G) uninfected quarters and (H) infected quarters.  Expression 
of CXCR1 was observed on leukocytes in both (I) uninfected quarters and (J) infected 
quarters. 
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Table 11: Presence of CXCR1+ and CXCR2+ staining in specific cell types in lactating 
bovine mammary tissue. 
 
IL-8 
Receptor 
Infection 
Status 
Cell Type 
Alveolar 
Epithelial 
Cells1 
Myoepithelial 
Cells1 
Fibroblasts1 
Leukocytes 
(CD45) 1 
CXCR1 
Uninfected 6/6 0/6 2/6 6/6 
Infected  6/6 0/6 4/6 6/6 
CXCR2 
Uninfected  6/6 0/6 0/6 6/6 
Infected 6/6 0/6 0/6 6/6 
 
 
1 Represents the number of cows that displayed positive staining for each cell 
type/receptor combination.  
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Figure 8: CXCR2 expression in mammary gland.  Red corresponds to CXCR2 
expression and green corresponds to cell specific markers.  Yellow indicates dual 
expression of both red and green markers and is indicated by arrow heads (◄).  
Negative controls receiving only secondary antibody, (A) GAR and (B) HAM, 
demonstrated no staining.  CXCR2 was expressed on alveolar epithelial cells in both 
(C) uninfected quarters and (D) infected quarters.  CXCR2 was not observed on (E, F) 
myoepithelial cells or (G, H) fibroblasts in uninfected or infected quarters.  Expression of 
CXCR2 was observed on leukocytes in both (I) uninfected quarters and (J) infected 
quarters. 
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Figure 9: CXCR2 bright edge staining pattern on epithelial cells.  Bright edges (◄) are 
observed in red CXCR2 stain (left), in green epithelial marker (right) and in composite, 
yellow images (middle).  This pattern was consistent across all six cows and in both 
uninfected and infected glands. 
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Discussion 
The ligands for CXCR1 and CXCR2 are present in the bovine mammary gland 
during both normal and disease states (Rainard et al. 2008).  However, we do not know 
the ability of native bovine mammary gland cell populations to respond to these ligands.  
The objective of this study was to determine which cell populations can respond to 
these ligands by evaluating the expression of CXCR1 and CXCR2 on the native cell 
populations in the bovine mammary gland.  Our results demonstrate alveolar epithelial 
cells express CXCR1 and CXCR2 in bovine mammary tissue.  Expression of CXCR1 
has not been demonstrated on these cells previously, but has been identified on human 
mammary stem cells(Ben-Baruch 2003).  This suggests the potential for CXCR1 
expression on differentiated mammary epithelial cells.  CXCR2 expression previously 
has been demonstrated on lung alveolar epithelial cells in mice (Wislez et al. 2006).  
CXCR1 and CXCR2 also have been witnessed on mammary epithelial tumor cells 
(Miller et al. 1998).  The expression of these receptors on these various tissue types 
allows them to respond to ligands released during and infection state. 
 The observation of CXCR1 and CXCR2 expression on bovine mammary 
epithelial cells suggests these cells are capable of responding to ligands in the 
mammary gland environment.  For example, when bacteria enter the mammary gland,  
epithelial cells are typically the first cell type encountered and activate TLRs that initiate 
the immune response causing the subsequent release of inflammatory mediators, TNF-
α, IL-1, IL-8,GRO-α, β, γ, ENA-78 and NAP-2 (Boudjellab et al. 1998; Boudjellab et al. 
2000; Fitzgerald et al. 2007; Lahouassa et al. 2007; Rainard et al. 2008; Walz et al. 
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1991; Walz et al. 1989).  Binding of IL-8 to CXCR2 has been associated with the ability 
of mammary epithelial cell tumors to invade neighboring tissues and metastasize 
suggesting a role of this receptor in epithelial cell migration (Nannuru et al. 2011).  
Furthermore, metastasized tumors release higher levels of IL-8 then primary tumors 
further supporting that the ligand/receptor complex has a strong role in metastasis or 
migration of mammary epithelial cells (De Larco et al. 2001).  These data suggest the 
role of alveolar epithelial cells expressing CXCR1 and CXCR2 may be associated with 
increased survival and/or cell migration. 
Other evidence linking CXCR1 and CXCR2 expression on alveolar epithelial cells 
to migration was demonstrated by direct infusion of IL-8 into the bovine mammary 
gland.  Direct injection of IL-8 into the gland caused a subsequent increase in serum 
proteins within the milk (Watanabe et al. 2008).  Serum proteins in the milk suggests IL-
8 in the gland alters the blood-milk barrier (Watanabe et al. 2008). The infection state 
further alters the blood-milk barrier.  The breakdown of tight junctions, which are 
typically impermeable during lactation to separate milk from tissue, become leaky in 
response to TNF and interferon (IFN)-γ that are released in response to infection 
(Madara and Stafford 1989).  Degradation of the tight junctions frees epithelial cells 
from their alveolar structure potentially allowing them to respond to released IL-8 by 
migrating.  Given these pieces of evidence, future in vitro studies are needed in order to 
definitively conclude how bovine mammary epithelial cells respond to CXCR1 and 
CXCR2 binding ligand. 
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Basally concentrated CXCR1 (Figure 7 C, D) and apically concentrated CXCR2 
(Figure 9) expression could be linked to ligand availability.  GRO-γ is the predominant 
ELR+ chemokine present in normal milk and is a ligand for only CXCR2 which we 
witnessed to be apically concentrated (Rainard et al. 2008).  IL-8 has very low 
concentrations in the milk during an uninfected state (Rainard et al. 2008), suggesting 
basal secreted levels of IL-8 may be more concentrated in the parenchyma.  The 
predominant ligand for CXCR1 is IL-8 and CXCR1 is which we observed to be basally 
concentrated.  However, further studies focused on patterns of receptor expression on 
mammary epithelial cells could definitively decipher this relationship. 
As previously stated, CXCR1 demonstrates apical concentration and CXCR2 
demonstrates bright edge concentration.  The pan-cytokeratin marker used to identify 
epithelial cells typically demonstrates luminal and bright edge concentration, thus co-
expression is observed with CXCR2 (Figure 9) but not CXCR1 (Figure 7 C, D).  The 
co-expression of the keratins with CXCR2 appears to be coincidental.  Epithelial cell 
keratins are often concentrated to luminal edges in secretory structures or structures 
subjected to fluid pressures such as ducts and lumens (Schmid et al. 1983; Sun et al. 
1979).  It is unclear what the role of these luminal and bright edge concentrated keratins 
might play in the mammary gland and why CXCR1 does not co-express with them and 
CXCR2 does. 
Some mammary fibroblasts express CXCR1 (Figure 7 G, H) but not CXCR2 
(Figure 8 G, H).  Fibroblasts’ traditional role in inflammation has been to repair and 
restructure connective tissue (Singer and Clark 1999).  In releasing immune related 
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peptides and cytokines, including IL-8, they can initiate the immune response to 
invading pathogens or inflammatory cytokines (Kandasamy et al. 2011; Strieter et al. 
1989).  The expression of CXCR1 on mammary fibroblasts most likely serves the 
purpose of increasing migration to the site of infection.  Contrasting to our results, 
cultured human fibroblasts express CXCR2 but not CXCR1 suggesting expression on 
fibroblasts is species and/or tissue type specific (Moser et al. 1993).  Future studies 
focused on the role of CXCR1 on mammary fibroblasts are needed to demonstrate the 
role that this receptor/ligand complex has in mastitis.  However, we can speculate 
fibroblasts respond to IL-8 by migrating due to the constant remodeling within the 
mammary gland in response to an inflammatory state (Zhao and Lacasse 2008) and the 
role fibroblasts play in releasing immune peptides and cytokines (Kandasamy et al. 
2011).   
Leukocytes also express CXCR1 and CXCR2 in the bovine mammary gland.  
Our results show CXCR1 expression by approximately 10-50% of CD45+ leukocytes in 
the mammary gland and CXCR2 expression on approximately 5-30% of CD45+ 
leukocytes.  As our interest was in overall cell populations that express CXCR1 and 
CXCR2, we did not evaluate individual leukocyte populations.  However, based on prior 
research in other species and tissues, we predict neutrophils and T-cells are the 
predominant positive staining populations.  These receptors are expressed on 
neutrophils (Ahuja and Murphy 1996; Grob et al. 1990; Lee et al. 1992; Li and Gordon 
2001; Paape et al. 2002; Sprenger et al. 1994) and binding to its cognate ligand causes 
subsequent neutrophil migration to the site of infection and increased survival 
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(Baggiolini and Clark-Lewis 1992; Grob et al. 1990; Kettritz et al. 1998; Richardson et 
al. 2003).  Several other cell types could be expressing these receptors.   CXCR1 
expression has been witnessed on human dendritic cells (Sallusto et al. 1998), natural 
killer cells (Berahovich et al. 2006), CD4+ T-cells (Gasser et al. 2006), CD8+ T-cells 
(Takata et al. 2004), and eosinophils (Petering et al. 1999), while CXCR2 expression 
has been observed on eosinophils (Petering et al. 1999) and would presumably 
influence their migration and survival.  Prior studies have determined percentages of 
different leukocytes present within both uninfected and infected bovine mammary gland.  
Within a healthy gland, the majority are T-cells and antigen presenting cells (Nickerson 
and Heald 1982; Shafer-Weaver et al. 1996).  Within an infected gland the number of 
granulocytes, especially neutrophils, increase and become the dominant leukocyte 
population present (Nickerson and Heald 1982).  T-cells and antigen presenting cells 
have previously demonstrated CXCR1 expression and most likely account for the 
leukocytes expressing CXCR1 witnessed in healthy quarters.  Granulocytes also 
express CXCR1 and most likely account for the CXCR1 expressing cell types in 
infected quarters, along with some T-cells and antigen presenting cells.   Another large 
percentage of leukocytes in the mammary gland are B-cells (Shafer-Weaver et al. 
1996).  These cells, do not express CXCR1 and most likely account for the fraction of 
leukocytes not displaying CXCR1 expression.  CXCR2 also was observed on 
leukocytes in our study.  Previously CXCR2 has been witnessed on neutrophils and 
eosinophils, thus the CXCR2 expressing leukocytes are most likely these two cell types.  
Future studies examining leukocyte sub-populations will provide greater insight to which 
leukocytes are expressing CXCR1 and CXCR2 in the bovine mammary gland. 
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CXCR1 and CXCR2 expression were similar between uninfected and infected 
states indicating ligand presence determines if the downstream effects are observed.  
Basal levels of ELR+ chemokines such as GRO-α, GRO-β, GRO-γ, and IL-8 are 
released at all times from mammary epithelial cells, but upon exposure to bacterial 
pathogens the levels increase at least 30-fold (Lahouassa et al. 2007; Maheshwari et al. 
2003; Rainard et al. 2008).  Secreted basal levels most likely contribute to remodeling of 
the mammary gland and removal of senescent and damaged cells.  Recruitment of 
neutrophils and migration of local cell populations that play a large role in remodeling 
during lactation and the dry period (Capuco et al. 1997).  This remodeling process is 
critical to maintaining lactation and efficiency of the bovine mammary gland and 
expression of CXCR1 and CXCR2 receptors could contribute to this process.  In other 
species, CXCR1 and CXCR2 expression is typically linked to either neutrophils or tumor 
cells (Ben-Baruch 2003).  However, unlike bovines, lactation is temporary.  The ELR+ 
chemokine/CXCR1/CXCR2 axis may facilitate the continual maintenance of the 
mammary gland required to perpetuate lactation in bovines.  To properly confirm this 
tissue samples from a non-bred heifer, a non-lactating dry cow, and cows at various 
stages of lactation should be compared. 
The results of this study indicate that CXCR1 and CXCR2 are expressed 
constitutively on bovine mammary leukocytes and alveolar epithelial cells, with CXCR1 
expression on some fibroblasts.  We can speculate that these receptors may serve to 
induce cell migration, increasing host cell survival and modifying local 
chemokine/cytokine profiles based on previous research.  These processes are 
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essential to the routine maintenance and infection defense of the bovine mammary 
gland.  However, further in vitro studies will be required to conclusively determine if 
these receptors allow mammary gland epithelial cells, fibroblasts and leukocytes to 
migrate, survive, and modify chemokine/cytokine. 
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Genetic variation in CXCR1 haplotypes linked to clearance of Streptococcus 
uberis infection in an experimental challenge model. 
L. Siebert, S. Headrick, M. Lewis, B. Gillespie, C. Young, L. Wojakiewicz, O. Kerro-
Dego, R. Almedia, S.P. Oliver, G.M. Pighetti 
Abstract 
  Mastitis, an inflammation of the mammary gland, costs the dairy industry billions 
in lost profits annually.  The prevalence and loss associated with mastitis has made new 
genetic selection methods a goal of research. Previous research has identified amino 
acid changes at positions 122, 207, 245, 327, and 332 in the IL-8 receptor CXCR1 that 
result in three dominant amino acid haplotypes: VWHKH, VWHRR, and AWQRR.  We 
hypothesize different haplotypes will influence a cow’s resistance or susceptibility to 
developing mastitis.  To test this, Holstein dairy cows (n=40) were intramammarily 
challenged with S. uberis within three days post calving.  All cows developed mastitis 
based on isolation of S. uberis from the challenged quarter at least twice.  All cows 
(100%) with the VWHRR x VWHRR (n=5) and AWQRR x VWHRR (n=6) haplotype 
combinations required antibiotic treatment to clear infection and were significantly 
different from cows with a VWHRR x VWHKH (n=6) haplotype where only 33.33% 
required antibiotic treatment (p=0.0153).  Cows with a VWHRR homozygous haplotype 
displayed significantly higher milk (1.05 ± 0.21) and mammary (1.23 ± 0.17) scores and 
AWQRR x VWHRR cows had significantly lower milk (0.17 ± 0.18) and mammary (0.41 
± 0.14) scores then cows of all other haplotype combinations (p=0.0263 and p=0.0161 
respectively).   Homozygotes for the VWHRR haplotype also displayed significantly 
higher S. uberis bacteria counts (981.99 ± 1947.05) then cows of any other haplotype 
combination (p=0.0348).  Haplotype combination did not influence somatic cell counts 
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(p=0.1399) and milk yield (p=0.6126).  This evidence suggests VWHRR x VWHRR and 
AWQRR x VWHRR cows are highly susceptible but VWHKH x VWHRR cows are less 
susceptible to S. uberis based mastitis.  Furthermore, the genetic haplotype of the 
CXCR1 gene may have the ability to significantly influence the degree of inflammation 
observed and bacterial clearance without aid of antibiotic treatments, supporting that 
CXCR1 is critical for disease resistance.   
Introduction 
 Mastitis is an ongoing issue in the dairy industry that costs producers billions in 
lost profits annually in the forms of lost milk, antibiotic therapies, and extra labor costs 
(NMC 2005).  Improving overall herd quality through the use of genetic selection is a 
predominant goal in the dairy industry.  In keeping with this goal, efforts have been 
made to identify single nucleotide polymorphisms (SNPs) within immune genes related 
to phenotypic immune functions to help in genetic selection.  One such study by Grosse 
et al. (1999) surveyed a large array of bovine cytokines and cytokine receptors, among 
them the gene for CXCR1.  CXCR1 is the receptor for the immune mediator interleukin-
8 (IL-8).  This receptor-ligand complex is responsible for several key immune responses 
including neutrophil migration, increased host cell survival, and the modification of 
chemokine/cytokine profiles (Grob et al. 1990; Kettritz et al. 1998; Soehnlein et al. 
2008).   
Four SNPs were identified in the bovine CXCR1 gene, three were synonymous 
and the fourth caused a glutamine to histidine point mutation at position 245 in the 
amino acid sequence of CXCR1 (Grosse et al. 1999).  This SNP was published as 
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originating in CXCR2, but subsequent studies have revealed an improper annotation 
indicating the SNP is actually in the bovine CXCR1 gene (Lahouassa et al. 2008; 
Pighetti and Rambeaud 2006).  Further examination of the CXCR1 gene revealed the 
presence of the same four SNPs (+612, +777, +858, and +861) in several beef and 
dairy breeds and a fifth SNP (+684) in Holstein and Jersey dairy breeds was identified 
(Heaton et al. 2001; Youngerman et al. 2004b). 
More extensive studies evaluated the association of specific SNPs and 
haplotypes with mastitis.  Youngerman et al. (2004b) identified SNPs at +612, +684, 
+777, +858, and +861 in the CXCR1 gene.  Four of the SNPs were synonymous, but 
the +777 was linked to increased instance of subclinical and clinical mastitis 
(Youngerman et al. 2004a).  Leyva-Baca et al. (2008) recognized four SNPs associated 
with the CXCR1 gene: -1830, -1768, +344, and +777.  The +777 SNP corresponded to 
the previously identified amino acid change at position 245, but showed no correlation 
with increased somatic cell score (SCS), whereas the -1768 did, but only for the first 
and second lactations (Leyva-Baca et al. 2008).  A more in depth study of the +777 
SNP revealed associations with calcium signaling upon IL-8 binding (Rambeaud and 
Pighetti 2007), decreased neutrophil migration (Rambeaud and Pighetti 2005), 
decreased reactive oxygen species (ROS) generation from neutrophils to aid in 
bactericidal activities (Rambeaud et al. 2006), and increased neutrophil survival 
(Rambeaud et al. 2006).   
A compilation of SNPs in the CXCR1 gene also resulted in a change in the 
naming convention of the SNPs to correlate with Human Genome Variation Society 
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Guidelines (Pighetti et al. 2012).  A total of 11 polymorphisms were identified within the 
coding region of the bovine CXCR1 gene.  Six SNPs were synonymous, four induced 
amino acid changes (+365, +735 (formerly +777), +980, and +995), and one (+621) 
induced an early stop codon (Pighetti et al. 2012).  From the SNPs, amino acid 
haplotypes based on the positions were identified and three (VWHKH, VWHRR, 
AWQRR) were representative of more than 99% of the sample population (Table 12).  
The increase in specificity gained by combining individual SNPs could provide a more 
comprehensive and accurate means of genetic selection (Pighetti et al. 2012).   
The majority of previous studies on CXCR1 SNPs have relied on field studies 
(Grosse et al. 1999; Heaton et al. 2001; Leyva-Baca et al. 2008; Pighetti et al. 2012; 
Youngerman et al. 2004a; Youngerman et al. 2004b).  Field studies demonstrate that 
the CXCR1 SNPs can be linked to natural incidence of clinical mastitis and bacterial 
intramammary infection.  However, studies have yet to determine if direct bacterial 
challenge can also be tied to CXCR1 SNPs.  Based on the existing knowledge of each 
of the individual SNPs within the bovine CXCR1 gene, we suspect differences in a 
cow’s resistance and susceptibility to mastitis.  The goal of this study is evaluate the 
relationship between CXCR1 haplotype and a cow’s susceptibility to and clearance of 
infection following direct experimental challenge with Streptococcus uberis. 
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Table 12: Relationships between CXCR1 tagSNP haplotype and amino acid haplotype 
(Pighetti et al. 2012). 
 
tagSNPi Haplotype Nucleotide 
Haplotype 
Amino Acid 
Haplotype 
+621+735+816+980 365-621-735-980-995 122-206-245-327-332 
GCCA TGCAA VWHKH 
AGCG CAGGG AX 
GCAG TGCGG VWHRR 
GGCG CGGGG AWQRR 
 
i A tagSNP represents a group of SNPs in high linkage disequilibrium or non-random 
allele association, increasing the probability that SNPs will be inherited together 
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Materials and Methods 
Animal Selection 
This study was conducted using cows that were enrolled in a trial to test the 
effectiveness of a novel vaccine candidate against S. uberis, i.e.: Streptococcus uberis 
adhesion molecule (SUAM) (USDA-NIFA #2011-67015-30168).  The forty Holstein dairy 
cows used were clinically healthy, pregnant, and at the end of their first or second 
lactation.  Upon arrival at the ETREC Little River Dairy, the cows were allowed to 
acclimate to the facility two weeks prior to the initiation of research protocols.  Cows 
were divided into sets of ten based on expected calving date for ease of sampling and 
randomly assigned to the test vaccination (SUAM) or control vaccination (PBS) groups.  
Cows were housed separately from the core herd and cared for in accordance with 
ETREC Little River Dairy standard protocols.  All animal based work was done in 
accordance with Institutional Care and Use Committee (IACUC) guidelines. 
Vaccination 
The test vaccine contained 200µg recombinant SUAM that was isolated and 
purified by Dr. Stephen Oliver’s lab.  The control vaccine contained PBS instead of 
SUAM.  Both test and control vaccines contained the same adjuvant, Montanide 
ISA70VG with an adjuvant/antigen ratio of 70/30.  Each cow received a series of three 
vaccinations where the total volume of each dose was 2mL and given on alternate sides 
of the neck.  Vaccinations were administered in four week intervals at -84 days, -56 
days, and -28 days prior to expected calving date.  Following each administration, 
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injection sites and temperatures were closely monitored for adverse reactions to the 
vaccination. 
Challenge 
Approximately 1 week prior to calving, secretion samples were collected from 
each quarter to screen for bacterial presence and aid in selecting the challenge quarter.  
A frozen stock of Streptococcus uberis (UT888) was thawed and allowed to grow at 
37°C in Todd Hewitt Broth until turbid.  The culture then was serially diluted in PBS to 
approximately 2000 CFU/mL for infusion into the selected challenge quarter.  Each cow 
was challenged within three days after calving with a total volume of 5mL of the dilute S. 
uberis culture just after milking was complete.  The challenge inoculum was diluted 
serially and plated to determine the actual concentration of S. uberis delivered. 
Sampling and Basis for Antibiotic Treatment 
Time points for collection included: immediately before challenge (0 days) and 
then 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 14, 21, and 28 days post 
challenge.  Milk samples were used to identify the concentration of S. uberis present.  
Milk and mammary quarter scores were evaluated on a 0-3 scale.  Milk scores were 
defined as follows: 0=normal, 1=small flakes/clots, 2=large clots, 3=stringy, off color, 
watery, or bloody.  Mammary scores were defined as follows: 0=normal, 1=slight 
swelling, 2=moderate swelling, 3=edema.  Scores were evaluated by Charlie Young or 
Mark Lewis of the ETREC Little River Staff.  Three consecutive sets of severe scores (a 
2 in both milk and mammary scores, or a 3 in either) was considered grounds for 
antibiotic treatment.  Alternatively, if cows had not cleared S. uberis ≥ 14 days post 
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challenge of their own accord, antibiotic treatment was administered without clinical 
signs being present.  Somatic cell counts were collected and determined by the 
Tennessee Dairy Herd Information Association (DHIA) lab (Knoxville, TN).  Bacteria 
counts were determined by growth on blood agar plates and were evaluated by Barbara 
Gillespie or Susan Headrick of the Tennessee Quality Milk Lab (Knoxville, TN) using 
guidelines established in the NMC lab handbook (NMC 1999).  Milk yields were 
recorded daily by the milking system at the ETREC Little River Dairy. 
Haplotyping 
A blood sample from each cow was collected via jugular vein prior to the 
administration of the third vaccination and DNA was isolated from whole blood using 
UltraClean BloodSpin DNA Isolation Kit (Mo Bio, Carlsbad, CA).  Part of the CXCR1 
gene was amplified as follows: 1-2 ng of bovine genomic DNA was used as template in 
a 25 µl reaction containing specific primers and Eppendorf HotMaster Mix (Eppendorf 
North America; Westbury, NY) according to manufacturer's guidelines.  The conditions 
for amplification were as follows:  an initial hot-start denaturation occurred at 94oC for 
2min, followed by 50 cycles of 94oC denaturation for 15 sec, 62oC annealing for 20sec, 
and 72oC extension for 60 sec.  After the last cycle, a 10 minute final extension step at 
72oC was added before reactions were chilled to 4oC.  Amplified products were purified 
to remove primer and excess nucleotides.  Haplotypes were generated using PHASE 
(Stephens and Scheet 2005; Stephens et al. 2001).  The resulting DNA was sequenced 
using bovine CXCR1 specific primers (Youngerman et al. 2004a) and the CXCR1 
haplotype was determined based on nucleotide expression at tagSNP positions +621, 
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+735, +816, and +980 in the CXCR1 gene.  The haplotypes of two cows could not be 
resolved and were not included in analyses. 
Statistical Analysis 
The experiment was a randomized block design with repeated measures tied to 
time.  Significance was declared at p<0.05, and a trend was declared at p=0.05 to 
p=0.1.  A mixed model using glimmix tested the fixed effects of CXCR1 haplotype, 
vaccination, time and the two way interactions of each, with time declared as repeated 
measures.  The random effect of cow nested within CXCR1 haplotype also was 
included.  Many covariates were tested for each response variable and include: 
lactation number, challenge group, rectal temperature, days between calving and 
challenge (challenge interval), necessity of antibiotic treatment and time between 
vaccinations and challenge.  Of these covariates, necessity of antibiotic treatment was 
used for milk scores, mammary scores, somatic cell counts, S. uberis counts, and milk 
yield.  Analyses were performed in SAS (Cary, NC) using a mixed model analysis of 
variation with Fisher’s LSD for means separation of numeric relationships and chi-
square for frequencies.  Three cows, 218 (AWQRR x AWQRR), 221 (AWQRR x 
VWHRR), and 230 (AWQRR x AWQRR) were excluded from all response variable 
analyses because they were sacrificed early in the trial for experimental reasons and it 
is unknown if they would require antibiotic treatment.  A significant influence of vaccine 
was not observed for any response variables and will not be discussed. 
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Results 
There were 40 Holstein dairy cows in this study.  The dominant haplotype 
combination was homozygous for AWQRR and represented 28.95% (11/38) of the 
cows.  The second most frequent haplotype combination was AWQRR x VHWKH 
representing 23.68% (9/38) of the cows.  The remaining three haplotype combinations 
represented smaller percentages of the population and are outlined in Table 13.   
The relationship between necessity of antibiotics and time to administration of 
antibiotics are summarized in Figure 10.  The majority of cows (74.29%, 26/35) in the 
study required treatment with antibiotics.  All cows with VWHRR x VWHRR or AWQRR 
x VWHRR haplotypes required antibiotic treatment and tended to be different from cows 
with VWHKH x VWHRR haplotype where only 33.33% needed antibiotic treatment 
(p=0.0838).  The remaining two haplotypes, AWQRR x VWHKH and AWQRR x 
AWQRR, had results between both extremes with 75% and 70% of cows needing 
antibiotic treatment respectively.  Cows with the AWQRR x VWHRR haplotype took 
significantly longer to require treatment, with the administration of the first treatment 
13.59 ± 1.73 days post challenge (p=0.0003).  The remaining four haplotypes required 
treatment at or before 4.02 ± 1.47 days post challenge.   
Milk scores or the degree if inflammation, observed at each time point 
demonstrated AWQRR x VWHRR cows had significantly lower scores then cows of 
other haplotypes, except for VWHKH x VWHRR cows, which were more comparable.  
Cows with the AWQRR x VWHRR haplotype combination never reached average milk 
scores ≥1 for an individual time point and averaged 0.1735 ± 0.1835 overall (p=0.0263).  
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In contrast, VWHRR homozygous cows reached high milk scores (≥1) within three days 
post challenge and remained high until nine days post challenge and had an average 
milk score of 1.048 ± 0.2094.  The remaining three haplotype combinations shared 
similarities with both extremes (Figure 11). 
Mammary scores for VWHRR homozygous cows were significantly greater than 
all other genetic backgrounds.  Average mammary scores ≥1 were reached within two 
days post challenge, remained elevated until 11 days post challenge, averaging 1.23 ± 
0.1668.  The AWQRR x VWHRR cows which had the lowest milk scores compared to 
most other genetic backgrounds also had significantly lower mammary scores than the 
VWHRR homozygous and AWQRR homozygous haplotype combinations averaging 
0.4123 ± 0.1442 (p=0.0161) (Figure 12). 
Somatic cell counts and S. uberis counts also were observed at each time point.  
Haplotype had no effect on somatic cell counts with all ranging between 106 and 107 
c/mL regardless of time point (p=0.1399) (Figure 13).  S. uberis counts were influenced 
by haplotype.  Cows with the VWHRR x VWHRR haplotype had significantly higher 
numbers of S. uberis isolated from their infected quarter in comparison to cows from the 
other four haplotypes (p=0.0348).  VWHRR x VWHRR cows averaged 981.996 ± 
1947.05 CFU/mL whereas the other four haplotypes were 4.108 ± 4.42 CFU/mL or 
lower (Table 14).  Milk yields were recorded on each day of sampling and were not 
influenced by haplotype (p=0.6126).  All haplotypes had average daily weights ranging 
between 23.21 and 27.34 ± 2.62 kilograms per cow and each haplotype group 
demonstrated a steady increase over time (Figure 15).  
119 
 
Table 13: Frequency of haplotypes observed in sample population of Holstein dairy 
cows. 
 
Haplotype Count Percentage 
VWHRR x VWHRR 5 13.16 
VWHKH x VWHRR 7 18.42 
AWQRR x VWHRR 6 15.79 
AWQRR x VWHKH 9 23.68 
AWQRR x AWQRR 11 28.95 
Total 38 100.00 
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Figure 10: Percentage of and time to antibiotic treatment for each haplotype following S. 
uberis intramammary challenge.  Letters (a, b) represent significant differences between 
haplotypes (p=0.0838).   
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Figure 11: The effect of CXCR1 haplotype combination on milk scores following S. 
uberis intramammary challenge.  A covariate of necessity of antibiotic treatment was 
included (p=<0.0001).  Letters (a, b) represent significant differences between 
haplotypes (p=0.0263). 
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Figure 12: The effect of haplotype on mammary scores following S. uberis 
intramammary challenge.  A covariate of necessity of antibiotic treatment was included 
(p=0.0002).  Letters (a, b, c) represent significant differences between haplotypes 
(p=0.0161).   
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Figure 13: The effect of haplotype on somatic cell counts following S. uberis 
intramammary challenge.  A covariate of necessity of antibiotic treatment was included 
(p=<0.0001). No significant differences were observed in somatic cell counts across 
haplotypes (p=0.1399). 
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Table 14: The effect of haplotype on S. uberis counts following S. uberis intramammary 
challenge.            
  
 Haplotypei 
Day VWHRR 
x 
VWHRRa 
VWHRR 
x 
VWHKHb 
VWHRR 
x 
AWQRRb 
VWHKH 
x 
AWQRRb 
AWQRR 
x 
AWQRRb 
0 0 0.01 0 0 0 
0.5 619.72 12424.73 20.41 25.22 18.04 
1 9714.68 162951.56 2296.61 72.32 67.04 
1.5 18257.3 40792.42 623.59 590.14 364.43 
2 70083.38 298.56 48.6 295.49 7969.93 
2.5 337238.32 169.47 0.71 1101.13 53153.56 
3 400230.59 6314.32 38.74 602.46 127893.25 
3.5 201136.67 269.71 430.84 892.44 188686.6 
4 791880.14 71.99 777.07 1315.69 66615.61 
4.5 302270.55 110.63 318.79 609.51 54650.87 
5 237818.62 33.05 2167.32 7754.51 27477.93 
5.5 613894.22 32.95 234.22 408.95 7742.82 
6 58667279 10.43 94.14 79.4 732.87 
6.5 1.456E+09 25.55 5.79 8.55 3.54 
7 2.16 0.18 0.65 0.22 0 
9 0.01 0 0 0.09 0 
11 0 0 0 0 0 
14 0.02 0.02 0.11 0 0 
16 1.69 0.03 0 0 0 
18 0 0.08 0 0 0.01 
21 1302.37 0.03 0.01 0 0.01 
23 47.84 0.02 0 0 0 
25 107505.49 0 0 0 1.64 
28 47.22 0 0 0 0 
SEM ii 413183348.8 29692.88 993.72 2004.05 57759.93 
 
i Haplotype combinations with different letters differ (p=0.0348) with a covariate of 
necessity of antibiotic treatment (p=0.0002). 
ii SEM: standard error of the mean. 
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Figure 14: The effect of haplotype on milk yield following S. uberis intramammary 
challenge.  A covariate of necessity of antibiotic treatment was included (p=0.2211).  No 
significant differences were observed in somatic cell counts across haplotypes 
(p=0.6126).  
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Discussion 
The objective of this study was to determine the association between CXCR1 
haplotype and resistance or susceptibility to S. uberis based mastitis.  The common 
observed infection rate for S. uberis following experimental challenge is about  70% 
(Rambeaud et al. 2003).  However, we observed a 100% infection rate based on S. 
uberis presence.  This difference in number of cows developing infection is most likely 
attributed to differences in days in milk (DIM).  Cows in our study were three or less DIM 
and cows in the Rambeaud et al. (2003) study were between 11 and 38 DIM.  Cows are 
more susceptible to developing mastitis within the periparturient period due mainly to 
decreased neutrophil function (Cai et al. 1994; Oliver and Sordillo 1988; Sordillo and 
Streicher 2002).  The 100% infection rate caused us to reevaluate our definition of 
resistance in this study.  As a result, we focused on the need for antibiotic treatment, 
which resulted in three groups.  The first group contained cows with haplotype 
combinations VWHRR x VWHRR and AWQRR x VWHRR where 100% of cows 
required antibiotic treatment.  Cows with the VWHRR x VWHRR haplotype combination 
were highly inflammatory.  They developed average milk and mammary scores ≥1 
within 2.5 days post challenge, reached S. uberis counts statistically higher than other 
haplotype combinations, and all required antibiotic treatment within seven days post 
challenge.  Contrastingly, the AWQRR x VWHRR haplotype combination still required 
100% antibiotic treatment but were much less inflammatory in response.  AWQRR x 
VWHRR cows did not reach milk or mammary scores ≥1 and had S. uberis counts 
statistically similar to all haplotype combinations besides VWHRR x VWHRR.  Half of 
the AWQRR x VWHRR cows received treatment within seven days post challenge as a 
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consequence of inflammatory milk and mammary scores.  The other half did not receive 
treatment until 18-26 days post challenge and were received antibiotic treatment 
because cows were still shedding S. uberis.  The second group contained AWQRR x 
VWHKH and AQWRR x AWQRR cows with only 70 or 75% requiring treatment.  The 
last group contained cows with the VWHKH x VWHRR haplotype combination where 
only 33.33% required antibiotic treatment.   Within the groups requiring less than 100% 
antibiotic treatment, cows developed elevated milk and mammary scores ≥1 within two 
days post challenge and had statistically similar S. uberis counts to all haplotypes 
except VWHRR homozygous cows.  Cows that required antibiotic treatment in the 
groups with less than 100% antibiotic treatment were all treated by 7 days post 
challenge for severe clinical signs. 
The variation observed amongst the different groups can potentially be explained 
by the theoretical influence of amino acid changing SNPs in the CXCR1 gene.  VWHRR 
homozygous cows required 100% antibiotic treatment within seven days post challenge 
because of severe clinical signs.  These cows are homozygous for the +365 SNP that 
corresponds to amino acid position 122 in the CXCR1 amino acid sequence.  The valine 
at position 122 has been associated with ligand binding and strength due to its location 
in the first transmembrane domain, which is essential for any downstream effects to be 
carried out (Leong et al. 1994; Monteclaro and Charo 1996).  These cows are also 
homozygous for the tryptophan amino acid at position 206 in the CXCR1 amino acid 
sequence.  This is a conserved amino acid across all of the observed haplotypes 
because the alternative ghis a stop codon that results in no receptor expression or a 
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truncated receptor which both result in an inability for CXCR1 to respond to ligand.  
Cows homozygous for the VWHRR haplotype are homozygous for the C allele at the 
+735 SNP and histidine at position 245 in the amino acid sequence.  The 245 position 
has been witnessed to associate with neutrophil migration, survival, and ROS 
generation as well as intracellular calcium signaling.  Expression of histidine at position 
245 instead of the conserved glutamine residue has been tied to decreases in these 
functions in homozygous cows (Rambeaud et al. 2006; Rambeaud and Pighetti 2007; 
Rambeaud and Pighetti 2005).  This suggests that VWHRR homozygous cows may 
have decreased ability to induce internal calcium signaling and subsequent neutrophil 
migration, survival, and ROS generation.  Furthermore, the +980 and +995 SNPs 
corresponding to arginine at positions 327 and 332 respectively in the amino acid 
sequence have been linked to the ability to bind internal mediators and initialize internal 
signaling, internalize the receptor and induce migration, although more importance is 
given to the 327 position (Fan et al. 2002; Fan et al. 2000; Raman et al. 2010).  
Expression of arginine at the 327 position in CXCR2 alters the KILAIHGLI motif and 
reduces the ability of the C-terminus to bind internal mediators and cause downstream 
effects such as receptor internalization and subsequent migration (Fan et al. 2002; Fan 
et al. 2000; Raman et al. 2010; Yang et al. 1999).  The potential decrease in internal 
signaling and receptor internalization that could be associated with VWHRR 
homozygous cows could allow S. uberis to establish infection easier and proliferate 
more within the gland.  The greater S. uberis load may lead to the highly inflammatory 
responses seen and the need for all to receive antibiotic treatment within seven days 
post challenge. 
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VWHRR homozygous and VWHKH x VWHRR cows displayed dramatic 
differences in their need for antibiotic treatment.  Only 33.33% of VWHKH x VWHRR 
cows required treatment as opposed to 100% of VWHRR homozygous cows.  Cows 
with the VWHKH x VWHRR haplotype combination share several similarities with 
VWHRR homozygous cows having one identical allele and the other allele differing in 
only the two terminal amino acids.  This suggests that they too may have decreased 
ability to induce neutrophil migration, survival, and ROS generation as well as internal 
calcium signaling (Rambeaud et al. 2006; Rambeaud and Pighetti 2007; Rambeaud and 
Pighetti 2005).  The terminal lysine and histidine residues are involved in the KILAIHGLI 
motif of the C-terminus of the CXCR1 receptor.  The KILAIHGLI motif is linked to 
adaptin-2/LASP-1 and HSP-70 interacting protein (Hip) binding to the C-terminus of 
CXCR1 (Fan et al. 2002; Fan et al. 2000; Raman et al. 2010).  Mutations within this 
motif have demonstrated decreased adaptin-2 or Hip binding resulting in decreased 
receptor internalization and subsequent migration (Raman et al. 2010). Cows with the 
VWHKH x VWHRR haplotype combination possess one mutated and one wild type 
haplotype for this motif suggesting they may have intermediate ability to bind adaptin-2 
or Hip and cause subsequent receptor internalization and migration.  However, because 
VWHKH x VWHRR cows displayed a decreased need for antibiotic treatment compared 
to VWHRR homozygous cows, this suggests that the C-terminal amino acid positions 
327 and 332 play a greater role in the ability of CXCR1 to properly respond to ligand 
stimulation in comparison to the 245 amino acid.  Furthermore, these terminal amino 
acids are most likely responsible in providing some VWHKH x VWHRR cows with the 
ability to clear S. uberis mastitis without the aid of antibiotic treatment. 
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 Cows with the AWQRR x VWHRR haplotype combination also required 100% 
antibiotic treatment, but were much less inflammatory then VWHRR homozygous cows.  
Their lower inflammatory response suggests the AWQRR haplotype may impair the 
ability to kill S. uberis efficiently.  These cows are heterozygous for the +365 SNP that 
corresponds to amino acid position 122.  The 122 position is conserved across five 
species and has been linked to ligand binding and strength due to its location in the first 
transmembrane domain (Leong et al. 1994; Monteclaro and Charo 1996; Pighetti et al. 
2012).   An amino acid change from valine to alanine could cause a conformational 
change or alter the hydrophobicity of the transmembrane domain and potentially result 
in a reduced ability to bind ligand or reduced binding strength (Leong et al. 1994; 
Monteclaro and Charo 1996).   These cows are also heterozygous for the 245 amino 
acid position.  In previous studies, cows that are heterozygous at the 245 position 
display have displayed neutrophil migration, survival, ROS generation, and internal 
calcium signaling ability similar to both homozygous extremes (Rambeaud et al. 2006; 
Rambeaud and Pighetti 2007; Rambeaud and Pighetti 2005).  Overall, this suggests the 
AWQRR haplotype could be impaired in ligand binding as well as adaptin-2 or Hip 
binding and subsequent receptor internalization and migration.  The proposed abilities 
of each haplotype within the AWQRR x VWHRR haplotype combination suggest they 
may have decreased ability to bind ligand and carry out subsequent downstream effects 
of ligand binding.  This could explain the low inflammatory response coupled with the 
inability to completely clear S. uberis from the gland and require antibiotic treatment due 
to S. uberis’ continued presence witnessed with these cows.   
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The remaining two haplotype combinations, AWQRR x VWHKH and AWQRR x 
AWQRR, required intermediate levels (70-75%) of antibiotic treatment.  These 
haplotype combinations share similarities in proposed receptor ability with the other two 
antibiotic treatment groups previously discussed.  The AWQRR x VWHKH cows are 
heterozygous for amino acid positions 122, 245, 327, and 332.  This indicates they will 
most likely display intermediate abilities in ligand binding tied to position 122; 
intermediate neutrophil migration, survival, killing ability and internal calcium signaling 
tied to the 245 position; and intermediate abilities in initiating internal signaling based on 
the altered KILAIHGLI motif tied to positions 327 and 332 as previously discussed.  The 
AWQRR homozygous cows will most likely display decreased ability to bind ligand due 
to being homozygous for alanine at position 122 and decreased ability to bind adaptin-2 
or Hip to initialize internalization and subsequent migration because of the homozygous 
arginines at positions 327 and 332 altering binding ability of the KILAIHGLI motif.  The 
proposed abilities of the AWQRR x VWHKH and AWQRR x AWQRR cows can be 
linked to the responses witnessed for these cows within our study where the majority 
(70-75%) of cows required antibiotic treatment.  Those cows that required antibiotic 
treatment displayed inflammatory signs and were treated within 7 days post challenge 
indicating a possible inability to properly control the infection through immune 
responses. 
Increased somatic cell counts are often associated with a state of infection within 
the mammary gland because immune cells are heavily recruited to the site to fight 
infection.  Somatic cells are present within milk when the mammary gland is healthy at 
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lower concentrations, generally ≤ 200,000 c/mL, but increase dramatically upon 
incidence of infection to about 700,000 c/mL or higher, but can vary depending on 
pathogen (Bannerman et al. 2004; Rambeaud et al. 2003).  The findings of this study 
followed a similar pattern with somatic cell counts originating at approximately 150,000 
c/mL and resulting in over 8,000,000 c/mL.  Because of the association of the 245 
amino acid position with neutrophil migration (Rambeaud and Pighetti 2005), initial 
thoughts were that somatic cell counts would differ based on amino acid expression at 
position 245.  However, several studies have provided conflicting results.  Youngerman 
et al. (2004a) demonstrated Holsteins heterozygous at the 245 position displayed higher 
somatic cell scores (SCS) than Holsteins homozygous for histidine at the 245 position 
and Jerseys showed no such association.  Subsequent studies did not confirm an 
association between the 245 position and SCS (Beecher et al. 2010; Goertz et al. 2009; 
Leyva-Baca et al. 2008).  Our study, looking at the effect of haplotype instead of a 
single SNP, also did not display differences in somatic cell counts.  The IL-8/CXCR1 
ligand-receptor complex is not the only complex responsible for neutrophil migration.  
Other ELR+ chemokines including, GRO-α, β, γ, ENA-78, IL-8, GCP-2 and NAP-2 are 
ligands for the functionally similar CXCR2 receptor (Ahuja and Murphy 1996; Lee et al. 
1992).  Binding of these ELR+ chemokines to the CXCR2 receptor has been 
demonstrated to induce neutrophil migration (Geiser et al. 1993; Lahouassa et al. 2008; 
Walz et al. 1991; Walz et al. 1989).  Thus it is possible that differences in somatic cell 
counts are not witnessed based on CXCR1 haplotype because the other ligand-receptor 
complexes aid in recruiting neutrophils.  Furthermore, during the infection state, the bulk 
of somatic cells in milk are neutrophils, but other cell populations are present and 
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include: macrophages, lymphocytes ( CD4+ and CD8+ T-cells) and epithelial cells 
(Boutinaud and Jammes 2002).  Thus, an increase in another subpopulation of somatic 
cells may contribute to the lack of variation observed.   
This research indicates there are differences in responses to S. uberis 
experimental challenge based upon CXCR1 haplotype.  All cows developed mastitis 
indicating resistance could not be attributed to CXCR1 haplotype in an experimental 
challenge model given under immune compromised conditions.  However, differences in 
susceptibility based on CXCR1 haplotype were observed relative to the need for 
antibiotic treatment as well as the degree of bacterial growth and inflammation.  Of 
these, cows with a VWHKH x VWHRR haplotype combination required only 33.33% 
antibiotic treatment and may represent a desirable genetic marker due to their proposed 
ability to clear infection efficiently without antibiotic treatment during a highly susceptible 
period.  
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Chapter V: Conclusion 
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The first objective of this study was to evaluate types of cells expressing CXCR1 
and CXCR2 in the bovine mammary gland.  We identified expression of CXCR1 on 
alveolar epithelial cells, fibroblasts and leukocytes. Expression of CXCR1 has been 
witnessed on mammary stem cells, cancerous mammary epithelial cells, and epithelial 
cells from other species and/or tissues, thus CXCR1 expression on alveolar epithelial 
cells in the mammary gland was not a novel discovery (Ben-Baruch 2003; Miller et al. 
1998; Wislez et al. 2006).   The expression of CXCR1 on both fibroblasts and 
leukocytes were not unexpected findings as CXCR1 has been observed on cultured 
human fibroblasts (Moser et al. 1993), neutrophils (Grob et al. 1990), dendritic cells 
(Sallusto et al. 1998), natural killer cells (Berahovich et al. 2006), CD4+ T-cells (Gasser 
et al. 2006), CD8+ T-cells (Takata et al. 2004), and eosinophils (Petering et al. 1999).  
Expression of CXCR2 on alveolar epithelia cells and leukocytes also was demonstrated.  
Neither expression of CXCR2 on alveolar epithelial cells nor leukocytes were 
unexpected due to the prior discovery of CXCR2 expression on cultured epithelial cells 
(Park et al. 2010), neutrophils (Sprenger et al. 1994), and eosinophils (Petering et al. 
1999). 
The results of the first objective indicate that not only leukocytes, but also 
alveolar epithelial cells and fibroblasts are capable of responding to released ELR+ 
chemokines indicative of an inflammatory state.  For neutrophils, binding of ELR+ 
chemokine to CXCR1 or CXCR2 induces migration, survival and modifies secreted 
chemokine/cytokine profiles (Baggiolini and Clark-Lewis 1992; Grob et al. 1990; Kettritz 
et al. 1998; Soehnlein et al. 2008).  Expression of CXCR1 and CXCR2 on alveolar 
epithelial cells, fibroblasts, and other leukocytes theoretically provides the same benefits 
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of increasing migration, increasing survival and modifying chemokine/cytokine profiles.  
Future studies should evaluate the in vitro abilities of bovine mammary alveolar 
epithelial cells, fibroblasts and leukocyte subsets for their abilities to migrate, survive 
and modify chemokine/cytokine profiles upon addition of ELR+ chemokines. 
Expression of CXCR1 or CXCR2 in human mammary tissue is typically linked to 
cancer cells (Ben-Baruch 2003; Charafe-Jauffret et al. 2009).  However, unlike the 
bovine mammary gland, lactation in the human mammary gland is a temporary state, 
thus native expression of CXCR1 and CXCR2 in the bovine mammary gland could be 
attributed to the perpetual state of lactation.  To test this, mammary tissue samples from 
non-lactating heifers, dried off cows, and cows of varying stages of lactation should be 
assessed for CXCR1 and CXCR2 native expression.  Furthermore, expression of the 
receptor does not demand a correlation to ligand secretion, indicating that the receptor 
may be present and unbound and only responds when ligand is released.  An 
examination of what transcription factors and promoter sequences allow CXCR1 and 
CXCR2 expression in the bovine mammary gland could better illuminate this 
relationship. 
The second objective of this study was to determine the association of CXCR1 
haplotype on resistance and susceptibility to direct S. uberis challenge.  We observed a 
100% infection rate resulting in the reevaluation our definition of resistance in this study 
that focused on the need for antibiotic treatment.  This resulted in three groups: 
VWHRR x VWHRR and AWQRR x VWHRR where 100% required antibiotic treatment, 
AWQRR x VWHKH and AQWRR x AWQRR where 70 or 75% required antibiotic 
treatment and VWHKH x VWHRR where 33.33% required antibiotic treatment.   
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The results from the second objective indicate that the combination of individual 
SNPs within a haplotype as well as the haplotype combination play an intricate role in 
the phenotype observed.  Cows homozygous for the VWHRR or AWQRR haplotype 
shared the terminal two arginine residues and all required treatment.  This indicates that 
the C-terminus involving the KILAIHGLI motif is essential for combating infection 
through internal binding of adaptin-2 or Hip and subsequent receptor internalization and 
chemotaxis (Fan et al. 2002; Fan et al. 2000; Raman et al. 2010).  Although focused on 
by several previous studies, the amino acid residue at position 245 does not appear to 
have as great an influence on observed phenotype as the terminal 327 and 332 
residues.  Further evidence of this comes from the VWHKH x VWHRR cows displaying 
the ability to clear the infection without the aid of antibiotics in the majority of cases.  
However, VWHRR homozygous and AWQRR homozygous cows did differ greatly in the 
phenotypic level of inflammation observed.  VWHRR cows were highly inflammatory 
and AWQRR homozygous cows displayed the least amount of overall inflammation of 
all observed haplotype combinations in this study.  This indicates that the 245 position 
may be greatly linked to the intensity of the generated immune response most likely tied 
to the neutrophil migration, survival, ROS generation and internal calcium signaling 
observed with the glutamine residue at this position (Rambeaud et al. 2006; Rambeaud 
and Pighetti 2007; Rambeaud and Pighetti 2005).  These cows also differed at the 122 
amino acid position.  The 122 position has been previously associated with ligand 
binding and strength and may also be associated with the differences observed 
between the two homozygous haplotype groups likely tied to the ability to bind ligand 
(Leong et al. 1994; Monteclaro and Charo 1996).   
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To further support these conclusions, transfectants representative of each 
haplotype group should be generated and evaluated in vitro for their ability to migrate, 
survive, and modify chemokine/cytokine profiles upon stimulation with ELR+ 
chemokines.  Furthermore, the infection state is associated with cellular damage.  
Damaged cells are typically cleared by macrophages (Gordon 1998).  If cows of a 
certain haplotype group (VWHRR x VWHRR) are less capable of resisting mastitis, the 
bacteria will be present within the gland in higher numbers and capable of causing more 
cell damage.  The end result will be more scar tissue and less active parenchyma to 
produce milk.  These cows would then be more likely to be culled from the herd at a 
younger age then cows of other haplotype groups due to decreased milk yield.  An 
evaluation of how long cows of each haplotype group stay in the active milking herd 
could divulge if a trend is present and if further studies are of interest. 
Coupling together the knowledge from these two objectives could be the 
beginning of understanding the important role that the CXCR1/IL-8 receptor-ligand 
complex plays in mastitis.  Based on our results, we know that several populations of 
cells are natively expressing CXCR1 in the bovine mammary gland and that differences 
are seen based on CXCR1 haplotype in response to experimental S. uberis challenge.  
Therefore, the proposed abilities of each haplotype can be linked not only to immune 
cells but also epithelial cells and some fibroblasts.  Combining the previously proposed 
in vitro studies to test the migration, survival, and chemokine/cytokine profiles of all cell 
populations expressing CXCR1 and each CXCR1 haplotype combination should 
provide invaluable information potentially leading to reduces mastitis.   
  
143 
 
References 
Baggiolini, M., and Clark-Lewis, I. (1992). "Interleukin-8, a chemotactic and 
inflammatory cytokine." Federation of European Biochemical Societies Letters, 
307(1), 97-101. 
Ben-Baruch, A. (2003). "Host microenvironment in breast cancer development: 
Inflammatory cells, cytokines and chemokines in breast cancer progression - 
reciprocal tumor-microenvironment interactions." Breast Cancer Research, 5(1), 
31 - 36. 
Berahovich, R. D., Lai, N. L., Wei, Z., Lanier, L. L., and Schall, T. J. (2006). "Evidence 
for NK cell subsets based on chemokine receptor expression." The Journal of 
Immunology, 177(11), 7833-7840. 
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, 
M.-H., Diebel, M. E., Monville, F., Dutcher, J., Brown, M., Viens, P., Xerri, L., 
Bertucci, F., Stassi, G., Dontu, G., Birnbaum, D., and Wicha, M. S. (2009). 
"Breast cancer cell lines contain functional cancer stem cells with metastatic 
capacity and a distinct molecular signature." Cancer Research, 69(4), 1302-
1313. 
Fan, G.-H., Yang, W., Sai, J., and Richmond, A. (2002). "Hsc/Hsp70 interacting protein 
(Hip) associates with CXCR2 and regulates the receptor signaling and 
trafficking." Journal of Biological Chemistry, 277(8), 6590-6597. 
Fan, G.-H., Yang, W., Wang, X.-J., Qian, Q., and Richmond, A. (2000). "Identification of 
a motif in the carboxyl terminus of CXCR2 that is involved in adaptin 2 binding 
and receptor internalization†." Biochemistry, 40(3), 791-800. 
Gasser, O., Schmid, T. A., Zenhaeusern, G., and Hess, C. (2006). "Cyclooxygenase 
regulates cell surface expression of CXCR3/1-storing granules in human CD4+ 
T-cells." The Journal of Immunology, 177(12), 8806-8812. 
Gordon, S. (1998). "The role of the macrophage in immune regulation." Research in 
Immunology, 149(7-8), 685-8. 
Grob, P. M., David, E., Warren, T. C., DeLeon, R. P., Farina, P. R., and Homon, C. A. 
(1990). "Characterization of a receptor for human monocyte-derived neutrophil 
chemotactic factor/interleukin-8." Journal of Biological Chemistry, 265(14), 8311-
6. 
Kettritz, R., Gaido, M. L., Haller, H., Luft, F. C., Jennette, C. J., and Falk, R. J. (1998). 
"Interleukin-8 delays spontaneous and tumor necrosis factor-α-mediated 
apoptosis of human neutrophils." Kidney International, 53(1), 84-91. 
144 
 
Leong, S. R., Kabakoff, R. C., and Hébert, C. A. (1994). "Complete mutagenesis of the 
extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged 
residues mediating IL-8 binding and signal transduction." Journal of Biological 
Chemistry, 269(30), 19343-19348. 
Miller, L. J., Kurtzman, S. H., Wang, Y., Anderson, K. H., Lindquist, R. R., and Kreutzer, 
D. L. (1998). "Expression of interleukin-8 receptors on tumor cells and vascular 
endothelial cells in human breast cancer tissue." Anticancer Research, 18(1A), 
77-81. 
Monteclaro, F. S., and Charo, I. F. (1996). "The amino-terminal extracellular domain of 
the MCP-1 receptor, but not the RANTES/MIP-1α receptor, confers chemokine 
selectivity." Journal of Biological Chemistry, 271(32), 19084-19092. 
Moser, B., Barella, L., Mattei, S., Schumacher, C., Boulay, F., Colombo, M. P., and 
Baggiolini, M. (1993). "Expression of transcripts for two interleukin 8 receptors in 
human phagocytes, lymphocytes and melanoma cells." Biochemical Journal, 
294, 285-292. 
Park, G., Masi, T., Choi, C. K., Kim, H., Becker, J. M., and Sparer, T. E. (2010). 
"Screening for novel constitutively active CXCR2 mutants and their cellular 
effects", in P. M. Conn, (ed.), Methods in Enzymology. Academic Press, pp. 481-
497. 
Petering, H., Götze, O., Kimmig, D., Smolarski, R., Kapp, A., and Elsner, J. (1999). "The 
biologic role of interleukin-8: Functional analysis and expression of CXCR1 and 
CXCR2 on human eosinophils." Blood, 93(2), 694-702. 
Raman, D., Sai, J., Neel, N. F., Chew, C. S., and Richmond, A. (2010). "LIM and SH3 
protein-1 modulates CXCR2-mediated cell migration." Public Library of Science 
One, 5(4), e10050. 
Rambeaud, M., Clift, R., and Pighetti, G. M. (2006). "Association of a bovine CXCR2 
gene polymorphism with neutrophil survival and killing ability." Veterinary 
Immunology and Immunopathology, 111(3–4), 231-238. 
Rambeaud, M., and Pighetti, G. (2007). "Differential calcium signaling in dairy cows with 
specific CXCR1 genotypes potentially related to interleukin-8 receptor 
functionality." Immunogenetics, 59(1), 53-58. 
Rambeaud, M., and Pighetti, G. M. (2005). "Impaired neutrophil migration associated 
with specific bovine CXCR2 genotypes." Infection and Immunity, 73(8), 4955-
4959. 
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., 
and Lanzavecchia, A. (1998). "Rapid and coordinated switch in chemokine 
145 
 
receptor expression during dendritic cell maturation." European Journal of 
Immunology, 28(9), 2760-2769. 
Soehnlein, O., Kai-Larsen, Y., Frithiof, R., Sorensen, O. E., Kenne, E., Scharffetter-
Kochanek, K., Eriksson, E. E., Herwald, H., Agerberth, B., and Lindbom, L. 
(2008). "Neutrophil primary granule proteins HBP and HNP1–3 boost bacterial 
phagocytosis by human and murine macrophages." The Journal of Clinical 
Investigation, 118(10), 3491. 
Sprenger, H., Lloyd, A. R., Lautens, L. L., Bonner, T. I., and Kelvin, D. J. (1994). 
"Structure, genomic organization, and expression of the human interleukin-8 
receptor B gene." Journal of Biological Chemistry, 269(15), 11065-72. 
Takata, H., Tomiyama, H., Fujiwara, M., Kobayashi, N., and Takiguchi, M. (2004). 
"Expression of chemokine receptor CXCR1 on human effector CD8+ T-cells." 
The Journal of Immunology, 173(4), 2231-2235. 
Wislez, M., Fujimoto, N., Izzo, J. G., Hanna, A. E., Cody, D. D., Langley, R. R., Tang, 
H., Burdick, M. D., Sato, M., Minna, J. D., Mao, L., Wistuba, I., Strieter, R. M., 
and Kurie, J. M. (2006). "High expression of ligands for chemokine receptor 
CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras." Cancer 
Research, 66(8), 4198-4207. 
 
 
146 
 
Vita 
 Lydia Jean Siebert was born on July 13, 1988, in Baltimore, Maryland.  She 
graduated class salutatorian from Harford Technical High School in Bel Air, Maryland, in 
2006.  After high school she attended the University of Tennessee, Knoxville, where she 
majored in microbiology and earned her Bachelor of Science degree, cum laude in 
Biology in December of 2010.  In December of 2013 she graduated from the University 
of Tennessee, Knoxville, upon successful completion of a Masters of Science in Animal 
Science. 
